Stockwinners Market Radar for May 03, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
WTW | Hot Stocks20:06 EDT Weight Watchers says two-year study shows long-term effectiveness of program - Weight Watchers announced results from a two-year study published today in The Lancet which found that adults with obesity referred to Weight Watchers for one year lost "significantly" more weight and were able to keep it off for longer compared to those who either received brief advice and self-help materials, or were referred to a 12-week Weight Watchers program. Those on both the 12- and 52-week Weight Watchers program also had greater blood sugar control and greater reductions in body fat than those on the brief intervention program. "For the first time we've shown that extending this to a full year leads to greater weight loss over a longer period and a lower risk of diabetes," commented lead author Amy Ahern. Specifically, at one year, participants assigned to 52 weeks of Weight Watchers lost, on average, more than twice as much weight as those in the brief intervention group. They were also more likely to lose 5% and 10% or more of their initial weight. Study participants attended a final measurement appointment at 24 months, a full year after treatment had ended. Although there was weight regain among all groups, the group assigned to 52 weeks of Weight Watchers, as compared to the other two groups in the study, experienced superior weight losses and improvements in waist and fat mass that were sustained even two years down the line.
|
LGIH | Hot Stocks19:59 EDT LGI Homes reports April home closings 365 - LGI Homes announced 365 homes closed in April, up from 341 home closings in April 2016. The company ended the first four months of 2017 with 1,126 home closings, compared to 1,185 home closings during the first four months of 2016. As of the end of April 2017, the company had 71 active selling communities.
|
FB | Hot Stocks19:18 EDT Facebook CEO weighs in on potential Messenger monetization - During the company's Q1 earnings conference call earlier, Facebook CEO Mark Zuckerberg weighed in on potential monetization opportunities in Messenger and WhatsApp: "We're already experimenting with a couple [monetization methods]. One is ads that actually display in News Feed - not in Messenger or WhatsApp - but that link to the ability to communicate with a business directly in Messenger or eventually WhatsApp... The other way is, of course, eventually showing paid content in Messenger whether that's in the inbox or in relevant ways throughout the product. But the top priority right now is just building up the base of organic interaction between people and businesses that they want to interact with, and once we get that to a big base, I think there are going to be a lot of opportunities to build the business."
|
SCON | Hot Stocks19:13 EDT Superconductor Technologies director acquires 200,000 common shares - In a regulatory filing, Superconductor Technologies director LeRoy C. Kopp disclosed the purchase of 200,000 shares of common stock at a price of $1.694 per share. The transaction, dated April 10, 2017, brings Kopp's total direct common stock ownership to 1.03M shares.
|
CABO | Hot Stocks19:05 EDT Cable One names Michael Bowker COO - Cable One announced that its board of directors appointed Michael E. Bowker as Chief Operating Officer effective May 2, 2017. Bowker will report to Julie Laulis, President and CEO of Cable One. As Chief Operating Officer, Bowker will oversee Cable ONE's daily operations and optimize operational processes, as well as provide leadership for technology, and help drive strategy through the company's residential and business channels. In his previous role as Senior Vice President and Chief Sales and Marketing Officer since June 2014, Bowker oversaw sales and marketing strategy, and all aspects of sales activity throughout Cable ONE, including advertising, residential and commercial sales. Bowker joined Cable ONE in 1999.
|
XOM | Hot Stocks19:04 EDT Exxon Mobil applies to cease to be reporting issuer in Canada - Exxon Mobil announced that it has applied to the Alberta Securities Commission, as principal regulator, and the Ontario Securities Commission for an order to cease to be a reporting issuer in Alberta, Ontario and British Columbia. ExxonMobil is not a reporting issuer in any other Canadian jurisdiction. If the order is granted by the ASC, ExxonMobil will cease to be a reporting issuer in any jurisdiction in Canada.
|
MTDR | Hot Stocks18:54 EDT Matador backs FY17 guidance given on March 23 - Sees oil production of 6.9 to 7.2 million barrels, an increase of 38% at the midpoint of 2017 guidance, as compared to 5.1 million barrels produced in 2016; Natural gas production of 33.0 to 35.0 billion cubic feet, an increase of 11% at the midpoint of 2017 guidance, as compared to 30.5 billion cubic feet produced in 2016; Total oil equivalent production of 12.4 to 13.0 million BOE, an increase of 25% at the midpoint of 2017 guidance, as compared to 10.2 million BOE produced in 2016; Adjusted EBITDA of $255 to $275 million, an increase of 68% at the midpoint of 2017 guidance, as compared to 2016 Adjusted EBITDA of $157.9 million. As provided in its 2017 guidance estimates, as updated during its Analyst Day presentation on March 23, 2017, Matador anticipates that it will incur capital expenditures of $400 to $420 million for drilling, completing and equipping operated and non-operated wells in 2017.
|
MTDR | Hot Stocks18:51 EDT Matador sees Q2 oil production increasing 2%-4% - As noted in both Matador's February 22, 2017 earnings release and its Analyst Day presentation on March 23, 2017, the Company has planned for more multi-well pad drilling on its Delaware Basin acreage in 2017 than in previous years, which will likely cause the cadence of its production growth to be somewhat uneven from quarter to quarter. As a result, Matador projects that its sequential production growth will be the highest in the first and third quarters of 2017. In addition, third quarter production growth should also benefit from initial production attributable to Matador's five-well drilling program in the Eagle Ford shale, as those wells are expected to be placed on production late in the second quarter or early in the third quarter of 2017. For the year as a whole, Matador continues to project that, at the midpoint of 2017 guidance, its oil production will increase by approximately 36% and its natural gas production will increase approximately 11%, respectively, from the fourth quarter of 2016 to the fourth quarter of 2017. As to the second quarter of 2017 specifically, Matador estimates that its oil production will increase by 2 to 4% and that its natural gas production will increase by 6 to 8%, resulting in total oil equivalent production growth of 3 to 5% from the first quarter of 2017. Natural gas production in the second quarter is expected to benefit from initial production associated with three recently completed non-operated wells in the Haynesville shale in the Company's Elm Grove asset area, which were placed on production by an affiliate of Chesapeake Energy Corporation early in the second quarter.
|
AAPL | Hot Stocks18:48 EDT Apple CEO says company will start $1B fund to promote U.S. manufacturing jobs - Tim Cook is speaking on CNBC.
|
BUD | Hot Stocks18:45 EDT AB InBev to acquire craft brewery Wicked Weed - AB InBev announced that "Wicked Weed Brewing, one of Asheville's most creative and fastest-growing craft breweries will be joining The High End, Anheuser-Busch's business unit focused on its craft and import brands." Terms of the agreement were not disclosed. Reference Link
|
CS | Hot Stocks18:42 EDT NCUA says recovers $400M from Credit Suisse - The National Credit Union Administration issued the following statement Wednesday: "Legal recoveries by the National Credit Union Administration on behalf of five failed corporate credit unions that purchased residential mortgage-backed securities have reached $5.1B... NCUA has received $400M from Credit Suisse for claims arising from losses related to purchases of residential mortgage-backed securities by U.S. Central Federal Credit Union, Southwest Corporate Federal Credit Union, and Western Corporate Federal Credit Union." The agency noted, "The Credit Suisse settlement covers claims asserted in 2012 by the NCUA board as liquidating agent for the three corporate credit unions in federal district court in Kansas. NCUA will dismiss its pending suit against Credit Suisse, which does not admit fault as part of the agreement." Reference Link
|
HZN | Hot Stocks18:33 EDT Horizon Global authorizes share repurchase program of up to 1.5M shares - In April, the Horizon Global board of directors authorized a share repurchase program. Under the program, Horizon Global may repurchase up to 1.5M shares of the company's common stock in amounts and at prices as the company deems appropriate, on the open market or through privately negotiated transactions, depending on market conditions and subject to other factors.
|
TGNA | Hot Stocks18:31 EDT Tegna board approves spin-off of Cars.com - TEGNA announced that its board of directors has approved the previously announced spin-off of Cars.com, which will create two publicly traded companies: TEGNA, an innovative media company with the largest broadcast group among major network affiliates in the top 25 markets; and Cars.com, a leading digital automotive marketplace. The spin-off will be effected through a pro rata distribution of all outstanding shares of Cars.com to TEGNA stockholders of record at the close of business on May 18, 2017. Stockholders will retain their TEGNA shares and receive one share of Cars.com for every three shares of TEGNA stock they own on the Record Date. Cars.com shares are expected to begin "regular way" trading on June 1, 2017. The spin-off remains subject to the conditions described in the preliminary information statement filed by Cars.com on Form 10 with the U.S. Securities and Exchange Commission. Upon completion of the separation, TEGNA will continue to trade on the New York Stock Exchange under the ticker symbol TGNA and Cars.com will trade regular way on the New York Stock Exchange under the symbol CARS. Holders of TEGNA common stock who sell TEGNA shares regular way on or before May 31, 2017 will also be selling their right to receive shares of Cars.com common stock in the distribution. Investors are encouraged to consult with their financial advisors regarding the specific implications of buying or selling TEGNA common stock before the distribution date. Prior to the separation, Cars.com will make a one-time cash distribution of $650M to TEGNA. Cars.com expects to enter into new credit facilities with borrowing capacity of approximately $900M and expects a portion of the facilities will remain undrawn at closing. It intends to invest in organic growth initiatives and selective acquisitions to create shareholder value and does not anticipate paying a cash dividend. It is expected that TEGNA's existing credit facility will remain in place following the transaction, and the company expects to target long-term leverage levels in line with its peers. The company intends to use the $650M tax free distribution from Cars.com and cash flow from operations to reduce leverage and, to that end, will extinguish its current share repurchase program, with plans to reassess in the future. TEGNA expects to pay a regular cash dividend of 28c per share annually. The company intends to continue investing in organic and strategic growth opportunities and also intends to maintain the financial flexibility to pursue strategic acquisitions when appropriate.
|
FB | Hot Stocks18:25 EDT Facebook CFO reiterates warning on revenue deceleration, expense ramp - Speaking during the company's Q1 earnings conference call earlier, Facebook CFO Dave Wehner again reiterated caution on ad revenue growth rates: "Turning now to the outlook. With regards to revenue, we continue to expect that our ad revenue growth rates will come down meaningfully over the course of 2017. We expect that ad load will play a less significant factor in driving revenue growth after mid-2017. We also expect desktop ad revenue growth rates to slow in Q3 when we begin to lap our efforts to limit the impact of ad blockers. We continue to expect that our FY17 payments and other fees revenue will decline compared to FY16... Turning to the expense outlook. We continue to expect that FY17 GAAP expenses will grow 40%-50% compared to FY16. I would note that as we look into 2017 and beyond, there are going to be a number of initiatives we believe are valuable to the community and to the company in the long term that are going to be net negative on our operating margin. We are embarking on a significant ramp-up in infrastructure supporting global growth, and we continue to expect that FY17 capital expenditures will be in the range of $7B-$7.5B, which is up over 50% compared to last year."
|
FIVN... | Hot Stocks18:12 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: Five9 (FIVN), up 11.1%... FormFactor (FORM), up 9.3%... Tableau Software (DATA), up 8.7%... Airgain (AIRG), up 7.4%... Fitbit (FIT), up 6.9%... Square (SQ), up 6%... Health Insurance Innovations (HIIQ), up 4.1%... CF Industries (CF), up 2.4%... Glu Mobile (GLUU), up 1.6%... AIG (AIG), up 1.6%... Prudential Financial (PRU), up 1.1%... MetLife (MET), up 0.2%. ALSO HIGHER: Tailored Brands (TLRD), up 8% after it announced a plan to wind down its partnership with Macy's (M) and after revised its earnings guidance for fiscal 2017. DOWN AFTER EARNINGS: Cheesecake Factory (CAKE), down 8%... Andersons (ANDE), down 5.6%... Mitel (MITL), down 5.4%... Avis Budet (CAR), down 5%... Nu Skin (NUS), down 3.8%... 3D Systems (DDD), down 3.6%... CenturyLink (CTL), down 3.5%... Facebook (FB), down 2.3%... Pioneer Natural (PXD), down 2.1%... Qorvo (QRVO), down 1.9%... Kraft Heinz (KHC), down 1.2%... Stamps.com (STMP), down 0.6%. ALSO LOWER: BioPharmX (BPMX), down 31.2% after the company reported results of its BPX-01 Phase 2b clinical trial... Lantheus (LNTH), down 8.9% after it announced an offering of 3M shares of common stock by holders... GoDaddy (GDDY), down 3.8% after it announced an offering of 24M shares of Class A common stock... AMAG Pharmaceuticals (AMAG), down 3.4% after it filed to sell $250M convertible senior notes due 2022.
|
MITL | Hot Stocks18:11 EDT Mitel to align operating expenses, to reduce workforce by roughly 10% - "We are pleased with our results in the first quarter which demonstrated solid operational execution. In Enterprise, we drove steady market share gains. We were especially pleased with our performance in the larger European markets, where Mitel's financial strength helps us to expand on our leadership position in the region," said Richard McBee, Chief Executive Officer. "Recurring cloud grew in-line with our expectations as orders continued to be strong, and we continued to ramp our installation capacity." McBee also commented, "With the mobile divestiture behind us we are taking proactive cost reduction actions to align our operating expenses with our current and future business investment needs. This includes a workforce reduction of approximately 10% expected to be completed between now and the end of the year. This is expected to generate an annualized savings of approximately $30 million. We anticipate taking a charge in 2017 in the range of $25 million to $35 million."
|
TSLA | Hot Stocks18:05 EDT Tesla CEO Musk says production of 1M units per year 'still quite likely' by 2020 - Says expects to sell 100,000 units of S, X, models in 2017.
|
LKSD | Hot Stocks18:01 EDT LSC Communications says awarded supply chain services contract - LSC Communications announced it has been awarded a multi-year Supply Chain Services agreement for the print production and warehousing of educational materials for Open Up Resources' Middle Grade Math curriculum.
|
BA | Hot Stocks18:00 EDT Boeing awarded $143.4M government contract modification - The Boeing Co., Mesa, Arizona, was awarded a $143,414,164 modification to foreign military sales contract for a directed change for the Saudi Arabia National Guard II and III unique modifications to 24 AH-64E Apache attack helicopters. Work will be performed in Mesa, Arizona, with an estimated completion date of April 1, 2022. Foreign military sales funds in the amount of $3,909,521 were obligated at the time of the award. U.S. Army Contracting Command, Redstone Arsenal, Alabama, is the contracting activity.
|
HTGC | Hot Stocks17:58 EDT Hercules Capital announces special meeting to approve advisory agreement - Hercules Capital announced it has filed preliminary proxy materials with the Securities and Exchange Commission for a special meeting of shareholders to seek approval for a proposed advisory agreement with Hamilton Advisers. "Hamilton has been organized by Manuel Henriquez, Hercules' Chairman, Chief Executive Officer, President and co-founder to act as the external adviser of Hercules. We intend for all of our existing management and personnel of Hercules to join Hamilton... Because of the continuity of our team, we do not expect Hercules' distribution rate or investment performance to be adversely impacted by externalization... we have structured the proposed external advisory relationship with Hamilton to align the interests of the Hercules shareholders with those of the advisor in a unique way. In addition to offering the opportunity for future third party expenses to be spread over a broader universe of investment vehicles, the proposed base management fee will decrease as the size of Hercules increases. Importantly, the incentive fee is also tiered," said the company. The company added, "We are seeking to pursue externalization for strategic reasons. While internal management has served our shareholders well in the past, we believe that the changing competitive environment makes externalization important." If the agreement is approved by shareholders at the special meeting on June 29, Hercules will become externally managed.
|
FIG | Hot Stocks17:53 EDT Fortress says raises $590M for secured lending fund - Fortress Investment Group announced the successful close of the Fortress Secured Lending Fund. The fund was oversubscribed, with total accepted capital of $590M, nearly 20% over an original target of $500M. "FSLF will become the primary funding source for the firm's established specialty finance lending business... FSLF is focused on making attractively priced, primarily senior loans secured by diversified portfolios of consumer and small business loans and receivables," the company noted.
|
TSLA | Hot Stocks17:51 EDT Tesla CEO Musk says Model 3 is not an upgrade from Model S - Says there has been some misconception on the issue. Says an upgrade to Model S is simply the newest Model S, not Model 3.
|
KPTI | Hot Stocks17:48 EDT Karyopharm and Anivive Lifesciences sign license agreement for verdinexor - Karyopharm Therapeutics announced their entry into a licensing agreement whereby Anivive licensed from Karyopharm exclusive worldwide rights to research, develop and commercialize verdinexor, KPT-335, for the treatment of cancer in companion animals. Under the terms of the agreement, Anivive will make a one-time upfront payment of $1 million to Karyopharm. Karyopharm is eligible to receive up to $43.5 million dollar payments from future regulatory, clinical and commercial milestones, assuming approval in both the United States (US) and the European Union. In addition, Anivive agreed to pay Karyopharm up to low double-digit royalty payments based on future net sales of verdinexor. "We admire Anivive's passion and dedication to innovation in the discovery and development of new veterinary medicines in the rapidly growing companion animal health marketplace," said Michael G. Kauffman, MD, PhD, Chief Executive Officer of Karyopharm. "Anivive has the expertise and resources to advance cutting-edge drug candidates like verdinexor toward becoming a potential new treatment for companion animals that may benefit from it. Therefore, we believe Anivive is the ideal partner to maximize verdinexor's value in veterinary medicine and look forward to working with them on future animal health technologies. This partnership enables us to monetize our non-core assets, as we continue to focus on advancing the development of selinexor in our lead human indications of multiple myeloma, lymphoma and liposarcoma."Dylan Balsz, Founder and Chairman of Anivive Lifesciences, commented, "We strive to identify and develop the most innovative and promising new therapies for pets, and we are highly encouraged by the clinical data Karyopharm has generated to date for verdinexor in canine lymphoma, as well as the overall potential of this promising compound." Kwansun Ahn, Chief Executive Officer of Anivive Lifesciences remarked, "We look forward to working with the team at Karyopharm and to building a strong, long-lasting relationship."
|
TSLA | Hot Stocks17:45 EDT Tesla says CEO Musk says 'executing well, quite optimistic about future' - Says "highly confident" all transport vehicles will go electric. Says Model S and Model 3 will be at same level of technology. Comments from Q1 earnings conference call.
|
HNR | Hot Stocks17:44 EDT Harvest Natural confirms dividend payment, trading termination and dissolution - Harvest Natural Resources Confirms Payment Of Dividend, Termination Of Trading, And Time Of Dissolution Harvest Natural expects that the payment of a cash dividend of $5.75 per share to the stockholders of record on April 24 will be completed on May 4, and trading in Harvest's stock on the NYSE will be terminated after the close of business on May 4. Since the record date of April 24, the stock has been trading on a due bill basis and will continue to do so until the close of business on May 4. As soon as possible after the close of business on May 4, Harvest will effect its stockholder-approved dissolution by filing its certificate of dissolution with the Delaware Secretary of State. At that time, Harvest will cease to be an operating company and will continue to exist, as required by Delaware law, only for the purpose of winding up its affairs. After dissolution, Harvest's stock will no longer be traded, and Harvest will close its stock transfer books.
|
ITRI RGCO | Hot Stocks17:37 EDT Itron says selected by RGC Resources to modernize distribution system - Itron (ITRI) announced that Roanoke Gas, a subsidiary of RGC Resources (RGCO), is collaborating with Itron to modernize its gas distribution system. "Roanoke Gas will utilize Itron to operate more efficiently and improve service to its customers... The utility will use Itron's cloud-based Field Collection System to collect meter data and provide it to meter data management and customer billing applications," it said.
|
MAS | Hot Stocks17:36 EDT Masco's Arrow Fasteber to be acquired by Hangzhou GreatStar Industrial - Hangzhou GreatStar Industrial, a global developer, manufacturer and supplier of hand and power tools, has entered into an agreement to acquire Arrow Fastener from parent company Masco. GreatStar, based in Hangzhou, China, is one of the largest hand tool manufacturers in Asia. The transaction is expected to close midyear in 2017, subject to customary closing conditions and regulatory approvals.
|
CPA | Hot Stocks17:34 EDT Copa Holdings reports minor changes in financial statement structure - Copa Holdings implemented a new business, planning and financial consolidation system. This system standardizes the structure and presentation of the financial statements through a new classification of the chart of accounts. This new classification of the chart of accounts resulted in the reclassification of certain lines in the statement of financial position and the statement of profit or loss. The company does not believe these reclassifications significantly affect the analysis and interpretations based on the financial information previously reported.
|
AEE | Hot Stocks17:33 EDT Ameren Missouri proposes plan for solar panels at Lambert Airport - Ameren Missouri announced plans for a new solar generation facility to be built at St. Louis Lambert International Airport. Energy produced there would be available for its customers through the Community Solar Program.
|
ASR | Hot Stocks17:32 EDT ASUR Airports reports total April passenger traffic up 19.1% y-o-y
|
WINT | Hot Stocks17:31 EDT Windtree Therapeutics delisting from NASDAQ May 5 - Windtree Therapeutics has received written notification from NASDAQ that it has determined to delist the company's shares from the NASDAQ Capital Market and will suspend trading in the company's shares at the open of business on Friday, May 5, since the company no longer maintains a minimum of $2.5M in stockholders' equity. The company has filed an application to have its shares quoted on the OTCQB Market under the symbol "WINT" and anticipates that its shares will begin to trade on the OTCQB effective Friday, May 5. The transition to the OTCQB does not affect the company's business operations, including the company's plans to complete and release top-line results from the AEROSURF phase 2b clinical trial by mid-2017.
|
PFE | Hot Stocks17:31 EDT Pfizer says OCTAVE program results published in NEJM - Pfizer announced that detailed results from the Phase 3 Oral Clinical Trials for tofAcitinib in ulceratiVE colitis clinical program were published in The New England Journal of Medicine. Data from all three pivotal Phase 3 studies - OCTAVE Induction 1, OCTAVE Induction 2 and OCTAVE Sustain - met their respective primary endpoints, demonstrating that tofacitinib citrate was more effective than placebo in inducing and maintaining remission in patients with moderate to severe ulcerative colitis. Remission was defined as a Mayo score of 2 points or lower, with no individual subscore exceeding 1 point, and a rectal bleeding subscore of 0. "The publication of results from the full Phase 3 OCTAVE clinical program is a significant milestone," said William J. Sandborn, MD, Chief, Division of Gastroenterology, Professor of Medicine at the University of California San Diego School of Medicine and study investigator. "This robust data set provides evidence that tofacitinib, if approved, could be an important new oral treatment option with the potential to help patients with moderate to severe active ulcerative colitis achieve and maintain remission."
|
AWI | Hot Stocks17:29 EDT Armstrong World selected for Long Island Rail Road-Grand Central connection - Armstrong World was selected to provide ceiling solutions for the Metropolitan Transportation Authority's East Side Access megaproject, the largest transportation construction project underway in the U.S., that will connect the Long Island Rail Road to a new concourse underneath Grand Central Terminal. The ceilings are scheduled to ship in early 2018.
|
RAIL | Hot Stocks17:26 EDT FreightCar America CEO says FY17 delivery range increased - FreightCar America CEO Joe McNeely said, "Overall market conditions remain challenging as demonstrated by continued weakness in orders for new railcars. While near term uncertainty still exists, we are confident that the cost reduction initiatives that we have implemented, our diversified product offering and our strong balance sheet have positioned the company to manage through the downturn. Finally, deliveries for 2017, including the cars delivered in the first quarter and orders received to date in the second quarter, are now expected to range between 4,200 and 4,400 railcars."
|
HIVE | Hot Stocks17:26 EDT Aerohive sees resuming year-over-year growth in 2H - "While there is more work to do, we believe we have turned the corner on the major challenges that affected our results last year and are now back on a positive trajectory, guiding to non-GAAP EPS of breakeven to $0.01 in the second quarter and expecting to resume year-over-year growth in the second half of 2017."
|
INN | Hot Stocks17:25 EDT Summit Hotel Properties sees FY17 adjusted FFO $1.34-$1.42 - Sees FY17 pro forma RevPAR growth 0.5%-2.5%.
|
INN | Hot Stocks17:25 EDT Summit Hotel Properties sees Q2 adjusted FFO 38c-40c - Sees Q2 pro forma RevPAR growth (1.5%)-0.5%.
|
MIC | Hot Stocks17:24 EDT Macquarie Infrastructure sees costs savings of $12M-$15M in 2018 - The implementation of MIC's previously announced shared services initiative resulted in a reduction in the rate of increase in general and administrative expenses. As anticipated, the savings were offset by expenses including primarily severance payments and consulting fees totaling $2.4 million and incremental expenses associated with acquisitions completed in 2016. The Company expects to realize annual cost savings of between $12.0 million and $15.0 million in 2018, compared with its 2016 baseline, as a result of the shared services initiative. Shared services provides back-office functions including Accounting, Human Resource, Tax, Information Technology and Risk Management support to each of MIC's operating entities. In February, MIC issued guidance with respect to deployment of an estimated $350.0 million across growth capital projects and small acquisitions by its existing businesses in 2017. Including the acquisition of the Oxford FBO, the Company has deployed approximately $117.0 million of growth capital year to date. MIC had a backlog of approved growth projects having a total value of approximately $280.0 million at the beginning of May.
|
MIC | Hot Stocks17:23 EDT Macquarie Infrastructure raises quarterly dividend to $1.32 per share - The MIC board of directors authorized a cash dividend of $1.32 per share, or $5.28 annualized, for the first quarter of 2017. The dividend will be payable May 18 to shareholders of record on May 15. The payment represents a 10% increase over the dividend paid for the first quarter of 2016. For the full year 2017, the company expects to increase its cash dividend by 10% over 2016.
|
MX | Hot Stocks17:21 EDT MagnaChip sees workforce reduction in track for $29M-$33m in cash costs - MagnaChip During reduced the workforce by approximately 140 positions in Q1, as part of a previously announced headcount reduction plan. This plan is expected to cut the workforce by over two times a similar headcount reduction plan in 2016 that affected 169 employees. Once completed, the workforce reduction will have an expected payback period of less than 1.5 years with an estimated annual cost savings between $23M-$27M. The company believes it remains on track to complete the planned workforce reduction within its cash cost range of $29-33M. During Q1, the company recorded early termination charges of $11.1M and made cash payments totaling approximately $10 million in connection with the headcount reduction. The cash payments were comprised of approximately $4M related to the early termination charge and the remaining relates to statutory severance. The Company expects to complete or substantially complete the planned workforce reduction by the end of Q2 and expects to record an additional early termination charge of approximately $1-2M in Q2 related to the workforce reduction.
|
WMB | Hot Stocks17:21 EDT Williams issues update on debt reduction - "Through first-quarter 2017, Williams has reduced its debt by $1.623 billion. As previously announced on Jan. 9, 2017, in conjunction with its financial repositioning plan, Williams expects to have excess cash available to reduce debt throughout 2017 after paying its dividend and other cash requirements. As a result, we expect to reduce Williams' parent-company debt by approximately $500 million for full-year 2017."
|
CXO | Hot Stocks17:19 EDT Concho Resources raises FY17 production growth view to 21%-25% from 20%-24% - Raises FY17 oil and natural gas production expense $5.75-$6.25 per BOE from $5.50-$6.00 per BOE.
|
CXO | Hot Stocks17:18 EDT Concho Resources sees Q2 production average 182-186 MBoepd
|
MUR | Hot Stocks17:07 EDT Murphy Oil backs FY17 CapEx view $890M
|
CMP | Hot Stocks17:05 EDT Compass Minerals sees Q2 Salt volumes 1.3M-1.7M tons
|
CPK | Hot Stocks17:05 EDT Chesapeake Utilities raises quarterly dividend 6.6% to 32.5c per share - The Board of Directors of Chesapeake Utilities voted to increase the quarterly cash dividend on the company's common stock from 30.5c per share to 32.5c per share. The Board's action raises the annualized dividend 8c per share from $1.22 per share to $1.30 per share, which represents a 6.6% increase. The 32.5c per share dividend will be payable July 5 to all shareholders of record at the close of business on June 15.
|
FLO | Hot Stocks17:00 EDT Flowers Foods announces enhanced organizational structure - At its annual leadership meeting, Flowers Foods announced an enhanced organizational structure designed to provide greater focus on the company's strategic objectives under Project Centennial, emphasize brand growth and innovation in line with a national branded food company, drive enhanced accountability, reduce costs, and strengthen long-term strategy. The new organizational structure establishes two business units, Fresh Bakery and Specialty/Snacking, and realigns key leadership roles. The company will transition to the new structure over the next several months with full implementation expected during fiscal 2018. The current Direct-Store-Delivery and Warehouse segmentation will remain until the new structure is in place.
|
AGRX | Hot Stocks16:58 EDT Agile Therapeutics to present additional Phase 3 SECURE data - Agile Therapeutic sannounced that data from its Phase 3 SECURE study will be presented at the interactive ePoster session during the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists being held May 6 - 9, 2017 in San Diego, CA. The SECURE study evaluated the clinical benefit of the investigational transdermal contraceptive patch AG200-15, known as Twirla, in a diverse, real-world population of women reflective of current weight trends in the United States. The ePoster will include efficacy and safety findings for the overall population and pre-specified body mass index categories, in addition to results on the bleeding profile that have not previously reported.
|
COG | Hot Stocks16:58 EDT Cabot Oil & Gas raises quarterly dividend 150% to 5c per share - The dividend will be paid on May 31 to all shareholders of record as of the close of business on May 17.
|
KAMN | Hot Stocks16:56 EDT Kaman raises low end of FY17 Aerospace segment sales outlook by $10M - "With improved visibility into the latter half of 2017, coupled with the improved order intake for our specialty bearing products, we have increased the low end of our Aerospace sales outlook by $10.0 million to $730.0 million." Sees FY17 Aerospace revenue $730M-$760M.
|
CAR | Hot Stocks16:55 EDT Avis Budget enters into new cooperation agreement with SRS investment management - Avis Budget Group announced it has entered into a new cooperation agreement with SRS Investment Management, the Company's largest stockholder for the last several years. The Company also announced that, effective May 3, 2017, it is terminating the stockholder rights plan it adopted earlier this year. Under the terms of the new cooperation agreement, SRS has agreed to standstill and voting commitments until January 2018, and will vote all of its shares in favor of the Company's nominees and other proposals at any meeting of the Company's stockholders during the standstill period, subject to certain exceptions. Brian Choi, SRS's representative, and Sanoke Viswanathan, a mutually agreed-upon independent director, will remain on the Company's Board of Directors. Messrs. Choi and Viswanathan joined the Board in first quarter 2016. "We are pleased to have put in place a new cooperation agreement with SRS, with whom we have had a constructive relationship for many years," said Ronald L. Nelson, Executive Chairman of Avis Budget Group. "The new agreement enables us to terminate the rights plan before its scheduled expiration, which we believe is in the best interests of the Company and all of its shareholders." Karthik Sarma, Founder and Portfolio Manager of SRS, said, "We look forward to maintaining our strong long-term relationship with Avis Budget Group under the terms of this new cooperation agreement." The complete agreement between SRS and Avis Budget Group, as well as the amendment to the stockholder rights plan, will be included in a Form 8-K to be filed with the Securities and Exchange Commission.
|
XPO | Hot Stocks16:52 EDT XPO Logistics reaffirms adjusted EBITDA, cash flow targets - XPO Logistics reaffirmed its full year targets for adjusted EBITDA of at least $1.35B for 2017 and at least $1.575B for 2018. The company also reaffirmed its 2017-2018 cumulative free cash flow target of approximately $900M, including at least $350M of free cash flow generated in 2017. The company said, "We started the year on a strong note by solidly beating our expectations for earnings, and continuing to expand margins in both transportation and logistics. In North American less-than-truckload, we increased operating income by a robust 49%, in part by running our line-haul, cross-dock and pickup-and-delivery operations more efficiently. Our market-leading position in e-commerce continued to drive growth in last mile and contract logistics, and our intermodal unit won the largest contract in any business line in XPO history."
|
BPMX | Hot Stocks16:52 EDT BioPharmX reports 'positive' results of BPX-01 topical minocycline for acne - BioPharmX announced that it achieved the primary endpoint in its phase 2b clinical trial evaluating BPX-011, the first completely solubilized topical minocycline gel product candidate for the treatment of moderate-to-severe acne. From the topline results for the study's primary endpoint, BioPharmX observed in both the 1% and 2% doses of BPX-01 statistically significant reductions in non-nodular inflammatory acne lesions when compared to vehicle. Based on these phase 2b results, BioPharmX continues to progress BPX-01 towards a phase 3 program.
|
CF | Hot Stocks16:52 EDT CF Industries backs FY17 CapEx view $400M-$450M
|
CF | Hot Stocks16:52 EDT CF Industries sees nitrogen demand remaining strong during spring - CF believes nitrogen demand remains strong during the spring application season for nitrogen-consuming crops, including the approximately 90 million acres of corn expected to be planted in the United States. Wet and cold weather in the Midwest that lasted from March into late April stopped field work and delayed ammonia applications there, with activity having accelerated more recently. Additionally, upgraded products such as urea and UAN will be required to make up for ammonia not applied during the fall or early spring application seasons. The global nitrogen supply surplus continues to pressure marginal producers in China and other regions. Chinese urea production costs are estimated to be $15-$20 per metric ton higher than the middle of 2016 due primarily to higher anthracite coal prices. Published operating rates in China during the first quarter averaged 57 percent, and there have been significantly lower Chinese urea exports so far this year. Urea exports from China during the first quarter were approximately 1.2 million metric tons, the lowest quarterly volume since the second quarter of 2013. CF continues to expect 5-6 million metric tons of total urea exports from China in 2017, a decline of up to 44 percent compared to 2016 and up to 64 percent compared to 2015. Even with significantly reduced Chinese urea exports, global trade flows are unsettled as nitrogen producers attempt to find new outlets for their production. India's absence from the global urea market through March created additional challenges for producers who might otherwise have sent product to that country. As nitrogen prices in North America rose through the fourth quarter of 2016 into the first quarter of 2017, the region became a target for exporters with a lack of options elsewhere. The substantial volumes sent to the region, coupled with higher North American production and changing buyer behavior, drove prices down significantly as the quarter progressed. Prices subsequently fell even lower as market participants liquidated positions. CF anticipates this uneven pricing environment to continue through 2017, with a spring increase possible before prices return to seasonally low levels during the summer.
|
SEMG | Hot Stocks16:50 EDT SemGroup announces natural gas pipeline project to serve active STACK play - SemGroup announced plans to build a natural gas pipeline to connect its processing complex in northern Oklahoma to the active STACK play in the central portion of the state. The Canton Pipeline is backed by firm commitments from an investment-grade counterparty and has an initial capacity of 200 million cubic feet per day. With additional compression, the pipeline could be expanded up to 400 million cubic feet per day to serve other producers in the area. The 24-inch-diameter natural gas pipeline will extend approximately 50 miles from SemGroup's Rose Valley processing facility in Woods County to north central Blaine County. The pipeline is expected to be in service by year-end 2017. "This project falls directly in line with our long-term strategic goals to achieve basin and customer diversification while optimizing our existing assets," said Wayne Ziegler, vice president of SemGroup's gas operations. "It significantly expands our Oklahoma asset footprint and allows us to better serve the growing gathering and processing needs within this active play." Also in the STACK play, SemGroup's jointly owned Glass Mountain Pipeline, LLC is constructing a 44-mile pipeline extension to deliver STACK crude to the Cushing storage complex with access to Mid-Continent and Gulf Coast refineries. The Glass Mountain Pipeline extension is expected to be in service in the fourth quarter of 2017.
|
PXD | Hot Stocks16:44 EDT Pioneer Natural backs FY17 capital budget $2.8B - "The budget includes $2.5 billion for drilling and completion activities, including tank batteries/saltwater disposal facilities and gas processing facilities, and $275 million for water infrastructure, vertical integration and field facilities."
|
PXD | Hot Stocks16:43 EDT Pioneer Natural reports Q1 average realized price $49.05 per barrel - Says production costs averaged $8.42 per BOE.
|
PXD | Hot Stocks16:43 EDT Pioneer Natural sees Q2 production 254-259 MBOED - Sees Q2 production costs $7.75-$9.75 per BOE. Sees total exploration and abandonment expense $20M-$30M.
|
ETP | Hot Stocks16:40 EDT Energy Transfer Partners reports WAHA Header, Trans-Pecos in service - Energy Transfer Partners announced that two natural gas pipelines in West Texas, the Trans-Pecos Pipeline and the Comanche Trail Pipeline, and the Trans-Pecos Pipeline WAHA Header are in service. Both pipelines and the WAHA Header are owned by affiliates of ETP, Carso Energy Corp. and MasTec, Inc. as part of long-term agreements with the Comision Federal de Electricidad, Mexico's federal electricity commission, to transport natural gas from the Waha Hub in Pecos County, Texas to the Texas-Mexico border. The Comanche Trail Pipeline and the WAHA Header went into service as scheduled on January 30, 2017. The 42-inch intrastate pipeline traverses 195 miles through Pecos, Reeves, Culberson, Hudspeth, and El Paso counties to the Texas-Mexico border in San Elizario, Texas, just south of El Paso, Texas. The Comanche Trail Pipeline is designed to transport 1.1 billion cubic feet per day of natural gas and presently includes seven delivery taps along its route for local economic development opportunities. The WAHA Header, located near the Waha Hub, is designed to accommodate 6 billion cubic feet per day of natural gas and connects to more than 10 different natural gas pipelines. The Trans-Pecos Pipeline went into service as scheduled on March 31, 2017. The 148-mile, 42-inch intrastate pipeline traverses Pecos, Brewster and Presidio counties and terminates at the Texas border near Presidio, Texas. The Trans-Pecos Pipeline is designed to transport 1.4 billion cubic feet per day of natural gas and presently includes six local delivery taps along its route. Additionally, the Trans-Pecos Pipeline entered into a cooperative effort to help West Texas Gas and the City of Presidio offset construction costs of a new pipeline that will connect to the Trans-Pecos Pipeline and deliver natural gas to the newly established Presidio Industrial Park. The new lateral pipeline is expected to be in service by June 2017.
|
CLVS | Hot Stocks16:40 EDT Clovis now expects ARIEL3 results by end of June - Clovis said in its earnings release, "Upon notification from the Independent Data Monitoring Committee in mid-April that the target number of progression events in the mutant BRCA population has been achieved, Clovis has initiated final activities in preparation for database lock and release of top-line ARIEL3 results. Top-line results from ARIEL3 are now anticipated by the end of June. Results from the trial remain blinded until the database lock occurs."
|
RMP | Hot Stocks16:39 EDT Rice Midstream backs annual distribution growth taget of 20% through 2023 - Targets DCF coverage of approximately 1.4x and leverage of less than 2.5x through 2019.
|
RYI | Hot Stocks16:35 EDT Ryerson says demand has improved in oil & gas, construction end markets - Ryerson intends to issue second quarter 2017 guidance in the second half of June. Qualitatively, demand has improved most notably in oil & gas and construction end markets while other industries in aggregate are showing more modest improvement. Given the increased metal consumption and price stabilization experienced in the first quarter, Ryerson anticipates higher average selling prices in the second quarter of 2017.
|
DIS | Hot Stocks16:33 EDT S&P upgrades Disney to A+ from A after review of peer companies - S&P Global Ratings said today that it raised its long-term corporate credit rating and debt ratings on The Walt Disney to A+ from A. At the same time, S&P raised short-term corporate credit rating on the company to A-1+ from A-1. The rating outlook is stable. "We recently completed an extensive peer review of the major U.S. investment-grade and high-speculative grade media, telecommunications, and cable companies we rate... As a result of this review, we have a more favorable view of Disney's long-term business prospects relative to its peers. We believe Disney will continue to successfully tap its deep reservoir of intellectual property to generate high demand content through its film and television studios... The stable rating outlook on Disney reflects our expectation that the company's overall business performance will remain strong, particularly at its film and TV studio division and at the cable networks, despite secular pressures in the U.S. We also expect that management will maintain its current financial policy, with adjusted leverage of less than 2x," the ratings agency and its analysts said.
|
HRTG | Hot Stocks16:33 EDT Heritage Insurance reports Q2 book value per share of $12.67 - Book value per share increased 6% as compared to Q1 2016 to $12.67.
|
ATSG | Hot Stocks16:28 EDT Air Transport Services backs FY17 adjusted EBITDA view in excess of $260M - ATSG expects that its Adjusted EBITDA from Continuing Operations for 2017 will be in excess of $260 million, based on its current growth programs and initiatives, and assuming deployments of ten additional 767s and two 737 freighter aircraft with lease customers through the last nine months of 2017. This forecast factors in the effect of the May relocation of Amazon hub operations from Wilmington to the Cincinnati regional airport, and the cessation of those operations formerly performed by ATSG's LGSTX Services business. ATSG currently projects 2017 capital expenditures of approximately $355 million, mostly for fleet expansion, including modification of eleven 767-300 aircraft.
|
GWR | Hot Stocks16:26 EDT Genesee & Wyoming unit completes acquisition of Pentalver Transport - Genesee & Wyoming announced today that its subsidiary GWI UK Acquisition Company has completed the acquisition of all of the issued share capital of Pentalver Transport from a subsidiary of APM Terminals, a subsidiary of A P Moller-Maersk. "G&W expects that the Pentalver acquisition will enable G&W to enhance its U.K. services by providing rail and road transportation solutions, as well as offering storage options at the ports and inland, and unlock efficiencies from shared services and enhanced asset utilization from Pentalver's trucking fleet and Freightliner's existing fleet of approximately 250 trucks that currently provide local collection and delivery haulage from Freightliner's inland terminals," it said.
|
RYN | Hot Stocks16:24 EDT Rayonier on track to achieve FY17 adjusted EBITDA guidance - "With our solid start to the year, we are on track to achieve our full-year Adjusted EBITDA guidance. In the U.S. South, we recently closed on previously-announced acquisitions totaling 95,100 acres in coastal Florida, Georgia and South Carolina. The acquisitions represent a meaningful upgrade of our portfolio, as they are comprised of well-stocked, highly productive properties located in some of the strongest markets in the U.S. South. We believe these acquisitions further position us to benefit from the ongoing U.S. housing recovery as well as the potential increase in U.S. lumber production that is expected to result from the recently announced duties on Canadian lumber imports. In the Pacific Northwest Timber segment, we expect a modest improvement in sawtimber prices as domestic mills increase production and as exporters compete for log supply in the region. In our New Zealand Timber segment, we expect strong performance driven by sustained levels of demand in both domestic and export markets. In our Real Estate segment, we continue to see solid demand for our Rural properties and remain optimistic about the long-term prospects for our Wildlight development project, which we expect will generate its first sales in 2017."
|
M TLRD | Hot Stocks16:22 EDT Tailored Brands, Macy's to wind down partnership - Macy's (M) and Tailored Brands (TLRD) announced their joint plan to wind down operations under the tuxedo rental license agreement Macy's, Inc. had established with Men's Wearhouse on June 9, 2015. "Macy's is always looking for new partnerships that benefit both parties, as well as our customers, and we are grateful to have had the opportunity to collaborate with Tailored Brands. While the partnership did not produce the level of sales we expected, we will continue to benefit from the insights we gathered," said Tim Baxter, chief merchandising officer at Macy's, Inc. "Both Macy's and Tailored Brands remain committed to putting our customers first, and we plan to fulfill customer orders and ensure a positive customer experience as we wind down the shops." The Tuxedo Shops at Macy's will continue to take new reservations until June 1, 2017, with operations winding down by July 14, 2017. All customers with outstanding rentals after this period will be contacted and offered the option of transferring their reservation to a nearby Men's Wearhouse or Jos. A. Bank store to ensure complete customer satisfaction for all events.
|
AIG | Hot Stocks16:21 EDT AIG adds $2.5B to share repurchase authorization - American International Group announced that its board of directors authorized the repurchase of additional shares of AIG Common Stock with an aggregate purchase price of up to $2.5B. During the three-month period ended March 31, 2017, AIG repurchased approximately $3.6B of AIG Common Stock, pursuant to prior authorizations from the Board of Directors. AIG repurchased an additional approximately $1.1B of AIG Common Stock through May 3, 2017. AIG's aggregate remaining share repurchase authorization, inclusive of today's announced $2.5B authorization, is approximately $3.8B.
|
CSII | Hot Stocks16:20 EDT Cardiovascular Systems says Q3 margins hit by recall costs - "The third-quarter gross profit margin decreased to 78.6% from 80.4% in the prior-year period. Gross margin was lower than anticipated due to a charge to cover the costs associated with the previously announced voluntary recall and replacement of the company's 7-10014 Saline Infusion Pump. The $1.5 million charge reduced gross margin by approximately 2.9 percentage points," said Cardiovascular Systems.
|
FB | Hot Stocks16:19 EDT Facebook reports headcount up 38%
|
LVLT | Hot Stocks16:19 EDT Level 3 sees FY17 adjusted EBITDA $2.94-$3B - Sees FY17 free cash flow $1.1B-$1.16B; CapEx 16% of total revenue; FY income tax rate around 38%.
|
FB | Hot Stocks16:19 EDT Facebook says mobile reaches 85% of Q1 ad revenue - "Mobile advertising revenue represented approximately 85% of advertising revenue for the first quarter of 2017, up from approximately 82% of advertising revenue in the first quarter of 2016," Facebook noted.
|
FB | Hot Stocks16:18 EDT Facebook shares down 1.7% after Q1 report
|
FB | Hot Stocks16:17 EDT Facebook reports Q1 total costs and expenses up 40% to $4.71B
|
ZUMZ | Hot Stocks16:17 EDT Zumiez reports April comparable sales increased 7.8%
|
FB | Hot Stocks16:17 EDT Facebook says no longer reporting non-GAAP EPS
|
FB | Hot Stocks16:14 EDT Facebook reports Q1 DAUs up 18% to 1.28B - Reports Q1 MAUs up 17% to 1.94B.
|
TSLA | Hot Stocks16:13 EDT Tesla rises 1% after Q1 report - Tesla shares are up $4.23, or 1.36%, to $315.00 in after hours trading.
|
MATX | Hot Stocks16:13 EDT Matson sees FY17 EBITDA 'approximating' 2016 figure of $289M
|
TSLA | Hot Stocks16:12 EDT Tesla sees year-to-date capex 'slightly over $2B' when Model 3 production starts - Tesla said: "We expect that year-to-date capital expenditures will be slightly over $2 billion by the time we start Model 3 production. We expect additional investments through the remainder of the year as we increase automation and add production capacity."
|
TSLA | Hot Stocks16:11 EDT Tesla sees Q2 non-GAAP Automotive gross margin to decline by about 250 bps - Tesla said: "Non-GAAP Automotive gross margin should decline by about 250 basis points in Q2 due to the absence of the one-time benefit of Autopilot software revenue recognized in Q1 and fluctuations in product mix. At the same time, we expect that Model S and Model X vehicle costs should continue to decline each quarter based on the execution of our roadmap to improve manufacturing efficiencies. We expect Q2 GAAP and non-GAAP operating expenses to be flat to slightly up from Q1, including expenses associated with the final stages of Model 3 development and growth in our customer support infrastructure."
|
TSLA | Hot Stocks16:10 EDT Tesla backs first half deliveries outlook of 47,000 to 50,000 vehicles - Tesla said in its quarterly letter: "Based on our current order and production rates, our first half outlook remains unchanged at 47,000 to 50,000 deliveries, which represents 61% to 71% annual vehicle delivery growth. Moving past Q2, particularly as Model 3 becomes available, one of our challenges will be to eliminate any misperception about the differences between Model S and Model 3. We have seen a belief among some that Model 3 is the newest and more advanced generation of Model S. This is not correct. Model S will always have more range, more acceleration, more power, more passenger cargo room, more displays (two), and more customization choices, and Model S, X and 3 will all have equivalent Autopilot functionality...We will provide guidance on vehicle deliveries for the second half of this year after we have started Model 3 production in July. Given that we will be ramping Model 3 production so quickly, as we've noted before, even a couple-week shift in timing can have a meaningful impact on total deliveries."
|
TEP | Hot Stocks16:10 EDT Tallgrass Energy Partners issues update on Ultra matter - "On April 12, Ultra Resources announced that it had completed its restructuring and emerged from bankruptcy. The reorganization plan contemplates payment of REX's $150 million claim within three months after Ultra emerges from bankruptcy. Based on the timing of Ultra's emergence, REX expects to receive its cash payment no later than July 12, 2017. TEP will receive its approximate 50 percent share of an expected distribution of approximately $150 million from REX resulting from Ultra's settlement payment."
|
TSLA | Hot Stocks16:08 EDT Tesla says Model 3 on track for initial production in July - Tesla said in its quarterly letter: "Model 3 activities related to vehicle development, manufacturing equipment installation and supplier readiness remain on plan to start production in July. Over the past several months, we have been deploying our internally-developed software into the vehicle fleet, to provide additional safety and convenience features for vehicles with the newest generation of Autopilot hardware."
|
EGL | Hot Stocks16:02 EDT Engility says wins $35M contract for nuclear consulting - Engility Holdings has been awarded a $35 million contract to provide specialized advisory services to the Defense Threat Reduction Agency's Nuclear Enterprise Support Directorate. The contract includes providing modeling and simulation, nuclear and countering weapons of mass destruction exercises, and highly specialized subject matter expertise. Engility will also perform nuclear safety, surety, security, accountability and reliability activities; mission assurance assessments; training; information technology services; and acquisition and program management support. The first quarter 2017 win represents a recompete of existing work. The Cost Plus Fixed Fee contract has a 1-year base and four option years.
|
BREW | Hot Stocks16:02 EDT Craft Brew backs FY17 CapEx $16M-$20M - Backs FY17 total CBA depletion change flat to growth of 6%. Backs FY17 total gross marign rate 30.5%-32.5%.
|
CE | Hot Stocks16:01 EDT Celanese completes acquisition of Nilit unit - Celanese announced it has completed the acquisition of the nylon compounding division of Nilit, a producer of high performance nylon polymers and compounds. Financial details of the transaction are not being disclosed at this time. "This acquisition further extends Celanese's leadership position in the engineered materials business to a global nylon solutions provider. The acquisition includes Nilit Plastics' nylon compounding product portfolio, customer agreements and manufacturing, technology and commercial facilities in Germany and China. In addition, the acquisition is complementary to the company's capabilities and track record of innovation, quality and service," it said.
|
BRO | Hot Stocks15:58 EDT Brown & Brown unit says resolves lawsuit brought by EEOC - Brown & Brown of Florida resolved a lawsuit brought by the Equal Employment Opportunity Commission in U.S. In the lawsuit, the EEOC claimed that Brown & Brown discriminated against an applicant by failing to hire her due to her pregnancy. "Brown & Brown denied the allegations and raised defenses to the claim, but reached a settlement to avoid protracted litigation and wasteful expense of attorneys' fees," it said.
|
AMZN | Hot Stocks15:42 EDT Amazon announces price reductions for certain AWS offerings - In a post to the AWS Blog, Amazon's Jeff Barr announced details for EC2 price reductions, which are effective immediately. The blog states: "In order to meet this wide range of preferences we are adding 3 Year No Upfront Standard Reserved Instances for most of the current generation instance types. We are also reducing prices for No Upfront Reserved Instances, Convertible Reserved Instances, and General Purpose M4 instances (both On-Demand and Reserved Instances). This is our 61st AWS Price Reduction." Reference Link
|
AMZN | Hot Stocks15:40 EDT Amazon Web Services announces EC2 price reductions - Reference Link
|
MMYT CTRP | Hot Stocks15:11 EDT MakeMyTrip nets $330M in purchase agreements with Ctrip, investors - MakeMyTrip (MMYT) announced that it has entered into definitive share purchase agreements for a placement of its ordinary shares to investors, which is expected to generate gross proceeds to the company of $165M. MakeMyTrip separately entered into share purchase agreements with Ctrip.com (CTRP) for the issuance of its ordinary shares to Ctrip and MIH Internet SEA Pte., a subsidiary of Naspers Limited, for issuance of the company's Class B convertible ordinary shares to MIH, which transactions will generate an additional $165M of gross proceeds to the company. The foregoing transactions with the investors, Ctrip and MIH are expected to general total gross proceeds of $330M. The company also entered into a registration rights agreement with the investors pursuant to which it has agreed to file a registration statement with the SEC covering the resale of the shares sold to the Investors. The company expects the closing of the transactions to occur on or about May 5.
|
AET | Hot Stocks15:03 EDT Aetna tells Bloomberg will pull out of Obamacare market in Virgina for 2018 - Aetna said it also will not sell off-exchange individual plans in Virginia, according to Bloomberg, citing a statement from the company.
|
XRM | Hot Stocks14:59 EDT Wynnefiels reports 5.92% stake in Xerium Technologies - As of May 1, Wynnefield owned in the aggregate 947,100 shares of Common Stock, constituting approximately 5.92% of the outstanding shares of Common Stock. The percentage of shares of Common Stock reported as being beneficially owned by the Wynnefield is based upon 16,010,059 shares outstanding as of June 30, 2016, as set forth in Xerium Technologies Annual Report on Form 10-K for the period ended December 31, 2016, filed with the Securities and Exchange Commission on March 1. Wynnefield are compelled to file a 13D following an astounding chain of events that included the release of first quarter 2017 earnings which evidenced clear signs that the challenging turnaround of the Xerium Technologies' operations had begun to take hold. This upbeat news was accompanied by the firing without cause of the architect of the turnaround effort, Harold Bevis, and the installation of his replacement, Mark Staton, an individual with no apparent experience managing a highly leveraged small capitalization industrial company. Wynnefield strongly feel that the Issuer's shareholders are entitled to a much more substantive explanation of this unexpected and, in the Wynnefield Reporting Persons' view, extremely untimely action. Channeling Bert Lance, Jimmy Carter's head of the OMB,"[I]f it ain't broke, don't fix it." This abrupt action was compounded by the Issuer's Board of Director's unethical decision to prohibit shareholders from participating in the Q&A session on the first quarter conference call held the afternoon of May 1st. During the Q&A session following the conference call, only sell-side analysts, interested mostly in details relating to their own earnings models, were permitted to participate. The shareholders, the Issuer's true owners, who have their own questions, including what was the cost to the Issuer of the WITHOUT CAUSE termination of Mr. Bevis, were left on hold. The Wynnefield Reporting Persons regard such a policy to be an egregious violation of shareholder rights. Such restrictions deprive Xerium's shareholders/owners from the collective probing of the actions of the Issuer's management, whom are employed by these shareholders. While providing exclusive access to sell-side analysts to ask questions during the public conference calls, Xerium then allows selective post-call access to large shareholders through "one-on-one" conversations. The dubious approach Xerium has chosen regarding its conference call and selective shareholder communications policy is one, in our opinion, that deserves SEC scrutiny.
|
APC... | Hot Stocks14:57 EDT Firestone explosion seen hanging over Anadarko, Colorado peers - Shares of Anadarko Petroleum (APC) are sliding following the results of an investigation into the tragic accident in Firestone, Colorado that killed two people back in April. According to the authorities, the home explosion was caused by gas related to an Anadarko well. Following the news, several Wall Street analysts downgraded the stock to Neutral-equivalent ratings, with Wells Fargo analyst David Tameron also cutting his rating for some of Anadarko's peers that operate in the same geographic area. FIRESTONE ACCIDENT: Yesterday, Anadarko provided a statement regarding the Frederick-Firestone Fire Protection District's results of investigation into a tragic accident in Firestone, Colorado. "The safety of our employees and the people who live and work in the communities in which we operate is our number one priority. Consistent with that, and out of an abundance of caution, last week we shut in our vertical wells in the Oak Meadows area and throughout the basin. [...] We will continue to cooperate fully with all ongoing investigations to ensure we fully understand the basis for the fire district's conclusions and that no stone is left unturned prior to any final determinations," said Al Walker, Anadarko Chairman, President and CEO. Back on April 17, an explosion killed two men in a recently built home located within 170 feet of a well that was drilled in 1993 and later acquired by Anadarko. State regulators had been investigating the cause behind the incident, and said yesterday that they have determined that an abandoned natural gas line that had been cut but not capped caused the explosion that destroyed the home, killing two people and critically injuring another. MOVE TO THE SIDELINES: In a research note today, Morgan Stanley analyst Evan Calio downgraded Anadarko to Equal Weight from Overweight after Colorado authorities determined that gas related to an Anadarko well caused the April 17 home explosion. The analyst told investors that he believes the potential for increased Colorado regulatory scrutiny provides a significant near-term overhang for the shares, particularly given the challenging energy environment and consensus negative sector outlook. Meanwhile, Macquarie analyst Paul Grigel downgraded Anadarko to Neutral from Outperform, also citing the overhang from the Firestone investigation. The analyst pointed out that he sees the direct near-term financial impacts as "bearable," but believes there will be an overhang on the stock until there is visibility on the impacts of the investigation. His peer at Wells Fargo voiced a similar opinion, cutting his rating on the shares to Market Perform following the preliminary findings of the Firestone Fire Department. Analyst David Tameron told investors that while there has not yet been an assignment of negligence or fault determined, there should be an overhang on Anadarko's shares until more clarity is reached. OTHER PLAYERS UNDER PRESSURE: Wells Fargo's Tameron also downgraded Extraction Oil & Gas (XOG) and SRC Energy (SRCI) to Market Perform, saying the preliminary findings regarding the tragic situation in Firestone will be an overhang on the Denver-Julesburg Basin players. All DJ basin-exposed names will remain under pressure given the fear of a potential regulatory response, he argued. Tameron also noted that the other two prominent DJ players he covers are Noble Energy (NBL) and PDC Energy (PDCE), which remain Market Perform rated. WHAT'S NOTABLE: Last night, Anadarko reported first quarter losses per share with items of (58c) and revenue of $3.77B. These results include certain items typically excluded by the investment community in published estimates. Following Anadarko's report, Citi analyst Robert Morris downgraded Cobalt International Energy (CIE) to Sell from Neutral and cut his price target for the shares to 10c from 50c. Anadarko's announcement that the Shenandoah-6 appraisal well, as well as a subsequent sidetrack, did not encounter an oil-water contact on the discovery's eastern edge "further undermines" Cobalt's value, he said. PRICE ACTION: In afternoon trading, shares of Anadarko have dropped over 7% to $52.17, while Extraction Oil & Gas has slid 5% to $15.04 and SRC Energy has fallen 7.5% to $7 per share. Meanwhile, Cobalt has also dropped about 8%, and Noble Energy and PDC Energy have each slipped by 4%-5%.
|
CRR | Hot Stocks14:48 EDT CARBO Ceramics CEO buys 20K shares - CARBO Ceramics CEO Gary Kolstad bought 20,000 shares of company stock on May 3 at an average price of $6.37 per shares, according to a regulatory filing.
|
XOM | Hot Stocks14:48 EDT Exxon Mobil in settlement talks with DOJ, EPA over Beaumont refinery incident - Exxon Mobil disclosed in a 10-Q regulatory filing: "On February 1, the U.S. Department of Justice issued a notification concerning potential enforcement and possible settlement to ExxonMobil Oil Corporation regarding potential violations of the Clean Air Act and various sections of the Environmental Protection Agency's Chemical Accident Prevention provisions at EMOC's Beaumont, Texas, Refinery. The DOJ and EPA contend that EMOC failed to identify hazards, failed to design and maintain a safe facility, and failed to mitigate the consequences of a claimed accidental release related to a flash fire that occurred on April 17, 2013. Additionally, based on an on-site inspection in 2013, the DOJ and EPA claim that EMOC failed to include all covered processes in its risk management program and failed to inspect certain process equipment in a timely fashion. The DOJ and EPA are seeking in excess of $100,000 in penalties and corrective actions to resolve the matter. ExxonMobil is in settlement discussions with the DOJ and EPA, and the parties have entered into a tolling agreement to facilitate settlement discussions."
|
EDU | Hot Stocks14:43 EDT UBS Asset Management reports 12.02% passive stake in New Oriental Education
|
PSX | Hot Stocks14:25 EDT Phillips 66 raises quarterly dividend 11% to 70c per share - The board of directors of Phillips 66 has declared a quarterly dividend of 70c per share on Phillips 66 common stock, representing an 11% increase. The dividend is payable on June 1 to shareholders of record as of the close of business on May 18. "Returning capital to our shareholders remains a priority for Phillips 66... We are committed to maintaining a growing, secure and competitive dividend as part of our disciplined approach to capital allocation," the company said.
|
FPP | Hot Stocks14:20 EDT FieldPoint Petroleum receives NYSE warning over stockholder equity level - FieldPoint Petroleum announced that on April 28, the company received notification from the NYSE that it was noncompliant with its listing standards. The company's stockholders' equity has been below the $2M threshold required for listed companies that have reported losses from continuing operations in two of its three most recently completed fiscal years and is now below the $4M threshold required for listed companies that have reported losses from continuing operations in three of its four most recent fiscal years.
|
HIL | Hot Stocks14:06 EDT Hill International trading resumes
|
HIL | Hot Stocks13:48 EDT Hill International CEO Richter resigns, Paul Evans named interim CEO - Hill International announced the following changes to executive leadership, effective immediately. David L. Richter has resigned as Chief Executive Officer of the company. During his 22 years with Hill, Richter held various leadership roles, including Vice President and General Counsel from 1995 to 1999, Senior Vice President and General Counsel from 1999 to 2001, President of Hill's Project Management Group from 2001 to 2004, President and Chief Operating Officer from 2004 to 2014, and CEO since 2014. Richter initiated and led the effort to make Hill a public company in 2006 and more recently initiated and led the sale of Hill's Construction Claims Group. Paul Evans, a Director on Hill's Board since August 2016, will assume the role of Interim Chief Executive Officer and director until a permanent replacement is appointed. Evans has extensive operational and leadership experience, most recently serving as Vice President, Chief Financial Officer and Treasurer of MYR Group. Further leadership changes include Craig Martin's appointment as Executive Chairman to a newly established Office of the Chairman. The Office of the Chairman is comprised of Craig Martin, Chairman, Paul Evans, Interim Chief Executive Officer and Director, Raouf S. Ghali, President and Chief Operating Officer and William H. Dengler, Jr. Executive Vice President and General Counsel. This committee represents all Hill International stakeholders: employees, clients and shareholders.
|
HIL | Hot Stocks13:47 EDT Hill International sets May 5 closing date for Construction Claims sale - Hill International announced that it has set a May 5, 2017 funding and closing date for the sale of its Construction Claims Group to Bridgepoint Development Capital, part of international private equity group Bridgepoint. On May 3, 2017, the Company and Bridgepoint entered into an amendment of the definitive Stock Purchase Agreement dated December 20, 2017 providing for, among other things, a funding and closing date of May 5, 2017, a reduction in the purchase price of $7M, from $147M to $140M in cash, an increase of $3M in the working capital that the company must deliver to Bridgepoint, from $35.4M to $38.4M, and additional specific indemnification of the buyer relating to certain potential CCG liabilities. Following the closing, Hill International will have 3,300 professionals in 60 offices worldwide, and provide program management, project management, construction management and other consulting services primarily to the buildings, transportation, environmental, energy and industrial markets.
|
SO | Hot Stocks13:42 EDT Southern Company says has 'A+' support from Trump on Vogtle - Says has gotten A+ support from Trump on Vogtle. Says has invested $5.4B in Vogtle expansion.
|
CBOE | Hot Stocks13:41 EDT CBOE Holdings reports April Futures ADV up 37% y/y - CBOE Holdings reported April monthly trading volume and average revenue per contract. The company said Futures ADV at CBOE Futures Exchange increased 37% from April 2016 and Options ADV at CBOE Holdings' four exchanges increased 24% from April 2016.
|
HIL | Hot Stocks13:38 EDT Hill International trading halted, news pending
|
OCLR... | Hot Stocks13:37 EDT Optical equipment makers wobble after Oclaro confirms China slowdown - Shares in the optical equipment space are declining Wednesday after Oclaro (OCLR) reported earnings and gave guidance after the close of trading Tuesday night. EARNINGS AND GUIDANCE: The company reported third quarter earnings per share of 23c on revenue of $162.2M, both higher than the consensus analyst views of 20c and $160.19M. Oclaro CEO Greg Dougherty noted that despite the industry being in a "seasonally week period," the company revenue jumped 60% compared to the same quarter last year. "We also achieved further customer and regional diversification, driven by sales growth in North America and Europe." Due to certain factors including "a significant slowing of demand in China," the company is anticipating a 10% sequential decrease in revenue for its fourth quarter, somewhere between $144M-$152M, significantly below the $164.58M analysts were expecting. "During April, we saw a significant slowing of demand in China which, coupled with an acceleration of the product transition from 100G CFP related products to the QSFP platform, will cause us to see an approximate 10% sequential decrease in our revenue in the June quarter. Despite lower revenue, we currently anticipate that our non-GAAP gross margin should remain around 40 percent as we maintain healthy profitability, further attesting to the strength of our financial model. We believe that the industry fundamentals, which drive the need for increased bandwidth and fiber optic components, remain intact and anticipate returning to revenue growth in the September quarter," Dougherty said. CHINA CONCERNS: Investors have been skittish on the prospects for optical communication companies since late last year, mostly centered on a slowdown in China spending. IHS Markit pointed out in a report from December 2016 that the pace of China's spending on optical network equipment slowed in Q3 of 2016. Sales in China dropped more than 19% sequentially, according to the report. Operators in the country still spent 14% more than in Q3 of 2015, thanks to deployments of 100G infrastructure led by China Mobile. A recent report from MKM Partners analyst Michael Genovese on Oclaro peer Finisar (FNSR) noted concerns on a number of fronts, "including China, for all products and 10G Datacom and Fibre Channel/SAN in the U.S. and Europe." Genovese saw Q4 demand in China weak due in part to lower demand from Huawei with weakness in product demand across the board, including WSS,10G Datacom and Telecom, and CFP2. According to the note, FiberHome and ZTE are also sluggish for Finisar. Oclaro CEO Greg Dougherty expanded on China during the company's earnings call on Tuesday night. "In April, we were informed by both of our major Chinese customers that demand would be even slower than previously anticipated for Q4. While both customers have signaled a slowdown for demand in the China market, the majority of the projected Q4 impact is coming from one customer. This customer cited both the reduction in demand for the Chinese market as well as in inventory correction," the CEO said. On a positive note, Dougherty sees the fundamental demand drivers in China still intact, and believes growth will return later this year from metro and provincial networks deployment. ANALYSTS WEIGH IN: In a report out Wednesday morning, Jefferies analyst James Kisner said he believes the post-earnings selloff in shares of Oclaro brings a compelling entry point. The analyst was pleased with the gross margin performance and thinks the outlook suggests "healthy industry dynamics and product differentiation." He lowered his price target for the shares to $12 from $14 and reiterated a Buy rating on the name. In a separate note out Wednesday, Needham analyst Alex Henderson pointed out that a C-Suite mandate to improve cash flow at Huawei is causing a more dramatic inventory correction than expected and that there was a "modest" amount of inventory to mop up at ZTE. PRICE ACTION: Oclaro is off its intra-session low, but down over 5% to $7.78 in afternoon trading. OTHERS OPTICALS DOWN: Shares of other comapnies in the space are also lower, including Finisar (FNSR), Lumentum (LITE), NeoPhotonics (NPTN), Acacia Communications (ACIA), Viavi (VIAV), and Applied Optoelectronics (AAOI).
|
MTCH | Hot Stocks13:36 EDT Match slips after earnings, 'conservative' guidance - Shares of Match Group (MTCH) fell in afternoon trading after the company reported results for the first fiscal quarter of 2017 and reaffirmed its revenue guidance for fiscal year 2017. Following the news, an analyst at Piper Jaffray maintained an Overweight rating on the stock. EARNINGS: After the market close yesterday, Match Group reported Q1 adjusted earnings per share of 12c on revenue of $298.76M, missing analysts' estimates of 13c and $293M, respectively. Average paid member count, or PMC, grew 16% year-over-year to 5.9M in the quarter. Commenting on the results, chairman and chief executive officer Greg Blatt said that the company is off to a "solid start" in 2017 and is "on track to have a strong year." Match also noted in its earnings statement that its board authorized a share repurchase program of up to 6M shares of common stock. Match said in presentation slides that Tinder, which an analyst recently called "the asset to watch," added 227,000 paid users in the quarter, below 245,000 in previous quarter. GUIDANCE: In slides to be presented on the company's quarterly earnings conference call, Match Group reaffirmed its fiscal 2017 revenue guidance of $1.26B-$1.305B as well as its adjusted EBITDA view for the fiscal year of $450M-$470M. In addition, the company guided for second quarter total revenue in the range of $303M-$313M and adjusted EBITDA for the quarter of $102M-$107M. Analysts currently expect Match to post FY17 revenue of $1.28B and Q2 revenue of $312M. STREET RESEARCH: Following the earnings report, Piper Jaffray analyst Samuel J. Kemp reiterated an Overweight rating on the stock, citing the "large" opportunity in monetizing Tinder, continued strength at Plenty of Fish, Meetic, and Pairs, as well as stable outlook in legacy Match brands. The analyst also said that the fact that Match called out "weird" January and February trends and was still able to beat revenue forecasts, along with the company pointing to accelerating March and April trends, leads him to believe that the company's guidance appears conservative. PRICE ACTION: In afternoon trading, Match Group shares are down 2.22% to $18.70.
|
SO | Hot Stocks13:28 EDT Southern Co.: Company has 'constructive dialogue' ongoing with Trump officials
|
SO | Hot Stocks13:26 EDT Southern Company to submit Kemper rate filing by June 3 - Sees updating regulators on Vogtle in a month or two. Says will file Kemper rate filing by June 3, 2017. Says Q1 retail sales fell 1.1%. Sees 2017 retail power sales unchanged to up 0.5%. Comments taken from Q1 earnings conference call.
|
EVA | Hot Stocks13:25 EDT Enviva raises quarterly distribution to 55.5c per unit - Enviva Partners announced that the board of directors of its general partner declared a quarterly distribution of 55.5c per common and subordinated unit. This distribution is 8.8% higher than the distribution for 1Q16 and 3.7% higher than the distribution for 4Q16. The quarterly distribution will be paid on May 30 to unitholders of record as of the close of business on May 18. "Our consistent operating performance combined with the initial benefit of the recently completed Sampson drop-down transaction gave us the confidence to take a meaningful first step toward our previously announced guidance of at least $2.35 per unit for FY17," said the company.
|
UPS | Hot Stocks13:18 EDT UPS unveils fuel cell electric delivery truck - UPS announced it will deploy a prototype extended range fuel cell electric vehicle in its Rolling Laboratory fleet of alternative fuel and advanced technology vehicles. "UPS is working with the U.S. Department of Energy and other partners to design a first-of-its-kind, zero tailpipe emissions, Class 6 medium-duty delivery truck that meets the same route and range requirements of UPS's existing conventional fuel vehicles... The first FCEV prototype will be deployed in Sacramento, Calif., where UPS will validate its design and core performance requirements by testing it on the street starting the third quarter of 2017. Current project plans call for additional UPS trucks to be validated with at least 5,000 hours of in-service operational performance. All of the trucks will be deployed in California due to that state's ongoing investment in zero tailpipe emissions transportation and installment of hydrogen fueling stations around the state," the company noted. Reference Link
|
VWR | Hot Stocks13:15 EDT VWR trading resumes
|
VWR | Hot Stocks13:10 EDT VWR trading halted, volatility trading pause
|
PRGO... | Hot Stocks13:10 EDT Generic drugmakers slip after DoJ searches Perrigo offices - Several names in generic drugmaking are lower Wednesday after U.S. authorities executed a search warrant of Perrigo (PRGO) as part of an ongoing price fixing probe. PERRIGO OFFICES SEARCHED: Wednesday morning, Perrigo disclosed that "search warrants were executed at the company's corporate offices associated with an ongoing investigation by the U.S. Department of Justice Antitrust Division related to drug pricing in the pharmaceutical industry. As has been previously disclosed by a number of companies, the Antitrust Division has been looking at industry-wide pricing practices." WHAT'S NOTABLE: According to media reports, the DoJ has been investigating price collusion within generics for more than two years, with targets including Perrigo, Akorn (AKRX), Taro Pharma (TARO), Teva (TEVA), Mylan (MYL), Endo (ENDP), Lannett (LCI), Impax (IPXL) and a subsidiary of Novartis (NVS). PRICE ACTION: Shares of Perrigo are down 6.15% in afternoon trading, while Impax, Teva and Lannett are lower by 5.76%, 4.27%, and 16.94%, respectively.
|
NSPR | Hot Stocks12:55 EDT InspireMD receives "intent to grant" patent notice from EPO - Reference Link
|
DO... | Hot Stocks12:48 EDT Notable companies reporting before tomorrow's open - Notable companies reporting before tomorrow's open, with earnings consensus, include Dominion Resources (DO), consensus 96c... Occidental Petroleum (OXY), consensus 7c... Regeneron (REGN), consensus $3.07... Zoetis (ZTS), consensus 48c... PPL (PPL), consensus 61c... Incyte (INCY), consensus ($1.00)... Apache (APA), consensus 13c... Willis Towers Watson (WLTW), consensus $3.35... Coca-Cola European Partners (CCE), consensus 32c... AmerisourceBergen (ABC), consensus $1.68... Viacom (VIAB), consensus 59c... Ball (BLL), consensus 70c... Ameren (AEE), consensus 39c... Church & Dwight (CHD), consensus 46c... Scripps Networks (SNI), consensus $1.19... Quanta Services (PWR), consensus 40c... Chesapeake Energy (CHK), consensus 19c.
|
FB... | Hot Stocks12:48 EDT Notable companies reporting after market close - Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus $1.12... Kraft Heinz (KHC), consensus 85c... AIG (AIG), consensus $1.08... MetLife (MET), consensus $1.27... Tesla (TSLA), consensus (81c)... Prudential (PRU), consensus $2.64... NXP Semiconductors (NXPI), consensus $1.35... Pioneer Natural Resources (PXD), consensus 16c... Manulife (MFC), consensus 38c... Williams (WMB), consensus 21c... Level 3 (LVLT), consensus 32c... Energy Transfer Equity (ETE), consensus 27c... Eversource (ES), consensus 82c... Lincoln National (LNC), consensus $1.61... American Water Works (AWK), consensus 53c... FleetCor (FLT), consensus $1.96... Square (SQ), consensus (8c)... CF Industries (CF), consensus 2c... Murphy Oil (MUR), consensus (2c)... Qorvo (QRVO), consensus 81c... Alliant Energy (LNT), consensus 43c... Albemarle (ALB), consensus 97c.
|
VZ IBM | Hot Stocks12:46 EDT Verizon to sell cloud, managed hosting service to IBM - Last week, Verizon (VZ) agreed to sell its cloud and managed hosting service to IBM (IBM). Additionally, Verizon agreed to work with IBM on a number of strategic initiatives involving networking and cloud services. "This agreement presents a great opportunity for Verizon Enterprise Solutions and our customers," Verizon said in a statement. "It is the latest development in an ongoing IT strategy aimed at allowing us to focus on helping our customers securely and reliably connect to their cloud resources and utilize cloud-enabled applications. Our goal is to become one of the world's leading managed services providers enabled by an ecosystem of best-in-class technology solutions from Verizon and a network of other leading providers." Verizon said it is notifying affected customers directly although it does not expect any immediate impact to their services as a result of this agreement. "We will formally notify and update customers as appropriate with additional information nearer the close of the deal," the company added. "We expect the transaction to close later this year." Reference Link
|
G | Hot Stocks12:38 EDT Genpact acquires BrightClaim and National Vendor, terms not disclosed - Genpact has acquired BrightClaim and their associated company National Vendor, both leading providers of integrated claims solutions to the U.S. property and casualty insurance market. The acquisition marries domain expertise with advanced technologies to fundamentally change how insurers manage the claims process, allowing carriers to create a seamless claims experience for their customers. Terms of the deal are not disclosed.
|
MGA... | Hot Stocks12:29 EDT Magna forms 'Technology Advisory Council,' says Tony Fadell joins group - Magna (MGA) announced earlier it has assembled a Technology Advisory Council to "contribute to future innovation projects, provide direction to Magna's technology road maps and identify additional business opportunities." The company continued, "The pace of innovation in the automotive industry is like nothing we have ever seen before, creating even more challenges and opportunities. At Magna, we welcome the challenge and aim to seize the opportunities by continuing to leverage our culture of innovation, while embracing a new level of innovation outreach... Advisory Council members will provide high-level strategic planning insights and experience in the areas of advanced driver assistance systems, environmental and automotive safety, overall industry trends, and next-generation technologies." The council's members include Tony Fadell, the former chief of Alphabet's (GOOG) Nest subsidiary.
|
GM GRUB | Hot Stocks12:26 EDT General Motors rolls out 'Maven Gig' - General Motors (GM) car sharing service Maven announced it "is expanding its flexible mobility platform to accelerate the gig economy. Maven Gig drivers are provided access to vehicles they can use for independent gigs that they choose, such as package delivery, food or grocery delivery, and ridesharing. The program is live in San Diego and will launch in San Francisco and Los Angeles later this year. Initial partners include GrubHub (GRUB), Instacart, Roadie and ridesharing services... Maven Gig is a low-risk way to test out the freelance economy and get your side hustle on. Potential drivers who do not own a vehicle or are unable to use their personal vehicle can now generate income by participating in the sharing economy." The service is priced at $229 per week. Reference Link
|
TWX AMZN | Hot Stocks12:16 EDT HBO Chair says will not renew Amazon Prime Channels deal after expiration - On Time Warner's (TWX) earnings call earlier this morning, HBO Chairman and CEO Richard Plepler said the company has seen "enormous momentum" for its HBO programming distributed through Amazon Prime Channels (AMZN). However, as the company sees progress in the sub-revenue acceleration in its digital business "I don't think you're going to see us extend or expand our relationship with our library programming on Amazon and we have no plans to do that beyond the end of the deal, which is the end of next year." The Amazon licensing pact was estimated to be worth $250M-$300M to HBO over the four-year term of the deal, Variety has noted. Reference Link
|
INTC | Hot Stocks12:07 EDT Intel names Navin Shenoy as general manager of data center group - In an email, Intel CEO Brian Krzanich announced changes to the company's leadership team: "Today I'm writing to share two important leadership transitions on our executive leadership team. Diane Bryant has made the difficult decision to take a leave of absence from Intel to tend to a personal family matter. She is stepping away for the next six to eight months. Given the extended duration, an interim leader for the Data Center Group is not possible. As a result, I have asked Navin Shenoy to take the position of general manager of DCG... Navin will now report to me in this role. Since joining Intel in 1995, Navin has held leadership roles in the CEO's office, sales and marketing, and the PC and tablet businesses. Most recently, as general manager of the Client Computing Group, he was responsible for the P&L, strategy and product development. Information about the succession plan for Navin as the general manager of CCG will be provided over the coming weeks. In the interim, Murthy Renduchintala will be CCG's acting leader. Navin and Diane have been instrumental to Intel's success and our executive leadership team over the past few years. They will work closely together for the next month to ensure a smooth transition for the organization and our customers. Management changes can be distracting, but it is critical that we all give Navin, Diane and the CCG leadership team our full support during this transition and focus on delivering leadership products and executing flawlessly. And, it goes without saying that my thoughts are with Diane. I look forward to welcoming her back to her next challenging role."
|
CAT | Hot Stocks12:02 EDT Caterpillar says SEC doesn't intend to recommend enforcement over Bucyrus - Caterpillar said in a regulatory filing: "Beginning on September 10, 2014, the SEC issued to Caterpillar subpoenas seeking information concerning the company's accounting for the goodwill relating to its acquisition of Bucyrus International Inc. in 2011 and related matters. On February 17, 2017, the company was notified by the SEC that it concluded its investigation and that it did not intend to recommend an enforcement action against Caterpillar in these matters."
|
SNI | Hot Stocks11:59 EDT Scripps Networks acquires Spoon University, terms not disclosed - Scripps Networks Interactive has reached an agreement to acquire millennial-focused media company Spoon University. "Spoon University captures the grassroots passion for food and community that is so important to millennials today," said Kathleen Finch, Scripps Networks Interactive's Chief Programming, Content & Brand Officer. "Food Network has become a significant force in digital and social food storytelling over the course of the last year, and this acquisition will provide us with the opportunity to build content, community and brand as we seek to accelerate our strategy in the sector."
|
CRMD | Hot Stocks11:57 EDT Sabby Management reports 8.65% passive stake in CorMedix
|
MTRN | Hot Stocks11:38 EDT Materion board increases quarterly dividend 5% to 10c per share - Materion Corporation announced that its Board of Directors declared a second quarter 2017 dividend of 10c per share of common stock, an increase of approximately 5%. The dividend is payable on June 2, 2017 to shareholders of record at the close of business on May 17, 2017. On an annualized basis, the amount of the dividend is 40c per share and equates to a yield of approximately 1% based on the Materion common stock price at the close of trading on May 1, 2017. The dividend represents a quarterly cash payout of approximately $2M, or $7.9M on an annualized basis. Subject to a continuing strong capital position and a determination that cash dividends continue to be in the best interest of shareholders, Materion intends to pay a quarterly dividend on an ongoing basis.
|
ETFC | Hot Stocks11:36 EDT E-Trade strength attributed to takeover speculation - The morning move higher in shares of E-Trade Financial follows traders having earlier circulated chatter of potential takeover interest in the company, according to trading contacts. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly's news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved. Shares of E-Trade spiked about an hour into trading and have held much of those early gains. The stock is up 95c, or 2.7%, to $35.76 near 11:30 am ET.
|
MCD | Hot Stocks11:27 EDT Goldman latest to upgrade McDonald's on U.S. potential - The shares of McDonald's (MCD) are rising despite the down market after Goldman Sachs upgraded the stock to Buy from Neutral. The outlook of the company's "experience of the future," or EOTF, initiative has become more certain and its U.S. business has multiple potential positive catalysts, the firm stated. The upgrade at Goldman follows the company's recent earnings report, which had been preceded by several other upgrades at rival research firms. THE FUTURE AT MCDONALDS: Noting that EOTF has gotten positive reviews from consumers, Goldman analyst Karen Holthouse says there is increased clarity about the initiative and its costs. The fast food chain's digital and delivery initiatives could boost its U.S. comp sales and McDonald's "has been more consistent with its (value) offers," according to Holthouse. Moreover, the company's decision to promote beverages nationally and food locally has been successful and could represent a viable strategy, the analyst stated. EARLY IN CYCLE: McDonald's recovery, which started in 2015, could still be in its early stages, since "its last period of comp outperformance (as measured by two year comps) versus peers lasted about eight years," Holthouse wrote. The analyst raised her price target on the shares to $153 from $126. WHAT'S NOTABLE: On April 17, Wells Fargo analyst Jeff Farmer upgraded McDonald's to Outperform from Market Perform. Refranchising should increase the company's margin and return on invested capital, causing the stock's multiple expansion to accelerate, Farmer predicted. Additionally, McDonald's first mover advantage in mobile order and pay should enable it to gain market share, wrote Farmer, who raised his price target range on the shares to $145-$150 from $125-$130. On April 18, Bernstein's Sara Senatore upgraded McDonald's to Outperform from Market Perform, saying that the company's U.S. business should benefit from a return of food inflation, better value, more menu innovation, and increased use of technology. Furthermore, the company is doing well in Japan, while it should get a boost from improving macro trends in Europe, wrote Senatore, who placed a $160 price target on the stock. PRICE ACTION: In morning trading, McDonald's rose 0.5% to $141.97, just off its recent 52-week high of $142.79.
|
MDT | Hot Stocks11:18 EDT FDA issues safety alert related to Medtronic NavLock Tracker - In a letter to health care providers dated May 2, the FDA said it is "providing information related to adverse events reported during or following procedures that involved the use of non-Medtronic surgical stereotaxic navigation instruments with Medtronic's NavLock Tracker." Medtronic is aware of occurrences of minor and serious injuries, including two patient deaths, following procedures that involved the use of non-Medtronic instruments with Medtronic's NavLock Tracker, the FDA said. As a result, Medtronic notified the Agency of plans to update its product labeling to clarify the use of non-Medtronic instruments with its NavLock Tracker. Reference Link
|
TWLO VG | Hot Stocks11:07 EDT Twilio plunges after warning of slowing Uber business - Shares of Twilio (TWLO) are sliding after the company reported quarterly results and warned of slowing business from its top client Uber. Following the news, Pacific Crest analyst Brent Bracelin downgraded the stock to Sector Weight, and several other Wall Street analysts lowered their price targets on the shares. RESULTS, UBER UPDATE: Last night, Twilio reported first quarter losses per share of (4c) and revenue of $87.4M, both better than expected. For the second quarter, the company said it sees losses per share of (11c)-(10c) and revenue of $85.5M-$87.5M, with consensus estimates at (8c) and $87.8M, respectively. Additionally, Twilio sees 2017 losses per share of (30c)-(27c) and revenue of $356M-$362M, both below consensus of (16c) and $370M. During the company's earnings call, Twilio's executives warned of slowing business from its lead client Uber. "1Q17, Uber accounted for roughly 12% of total revenue, and... we expect their contribution to decline further this year. Uber continues to grow rapidly, but they are changing the way they utilize and consume communications services. [...] We believe that Uber will remain an important customer for us going forward, but their tremendous growth and the resulting magnitude of their communication spend has resulted in this change in approach." MOVING TO THE SIDELINES: In a post-earnings research note, Pacific Crest's Bracelin downgraded Twilio to Sector Weight from Overweight based on the dislocation at Uber, revenue growth that could decelerate below 20% year over year before reaccelerating next year, planned investments that could widen operating losses above 2015 levels, and heightened competitive risks. The analyst noted that the one silver lining for Twilio is the fact that core revenue, excluding Uber and WhatsApp, accelerated slightly to 64% year over year last quarter and now accounts for 83% of sales. However, this might not be enough to offset all the competitive noise with a number of voice and messaging API alternatives that have surfaced in the last six months, he contended. OTHER ANALYSTS CUT TARGETS, REMAIN BULLISH: While Canaccord analyst Richard Davis lowered his price target for Twilio to $33 from $40, citing the faster than expected deceleration of Uber, he told investors that it would be ill-advised to sell while others are aggressively selling, adding that he expects the company's shares to likely retrace. He reiterated a Buy rating on the stock. Meanwhile, his peer at JPMorgan told investors in a research note of his own that he believes investors are overlooking two important considerations, namely that the company's broader base of business grew at a 45%-50% annualized clip in the first quarter and the point that "Uber is an extreme outlier and unlikely to represent the risk profile of other customers." Analyst Mark Murphy lowered his price target on Twilio shares to $33 from $36, but kept an Overweight rating on the name. Commenting on Twilio's announcement, JMP Securities analyst Patrick Walravens said that while the Uber situation naturally raises concerns that the company's services are undifferentiated and easily replaced, these types of web-scale businesses are outliers and Twilio remains well-positioned for long-term, profitable growth. He trimmed his price target on the shares to $33 from $37 but reiterated an Outperform rating. UBER CHANGES BENEFICIAL FOR VONAGE: In a research note this morning, Craig-Hallum analyst George Sutton told investors that he believes Twilio's "pain" is likely Vongage's (VG) Nexmo gain. Sutton noted that Vonage reports results next week and expects this Nexmo/Uber item will be a focus as will the growing evolution of its Amazon (AMZN) partnership. He reiterated a Buy rating and $10 price target on Vonage's shares. PRICE ACTION: In morning trading, Twilio has dropped about 27%, or $9, to $24.92 per share. Meanwhile, Vonage shares have gained 1.5% to $6.86.
|
POOL | Hot Stocks10:46 EDT Pool Corp. adds $150M to share repurchase program, boosts dividend 19% - Pool Corporation announced that its Board of Directors has authorized an additional $150M under its existing share repurchase program for the purchase of the Company's common stock in the open market at prevailing market prices or in privately negotiated transactions. This amount adds to the $46.6M remaining under our existing authorization, bringing our total authorization available to $196.6M. The company also announced that the Board has declared a quarterly cash dividend of 37c per share, a 19% increase over the previous quarterly dividend amount of 31c per share. The dividend is payable on May 31, to stockholders of record on May 17. As of May 2 there were 41,351,255 shares of common stock outstanding.
|
BMY... | Hot Stocks10:43 EDT Bristol-Myers cut to sell with Pfizer takeover seen as unlikely - The shares of Bristol-Myers (BMY) are falling after BMO Capital downgraded the drugmaker's stock to Underperform, the firm's equivalent of a sell rating, partly due to Pfizer's (PFE) CEO Ian Read having indicated yesterday that his company would not look to make a major acquisition in the near-term. In recent months there has been speculation that Pfizer would look to acquire Bristol-Myers. PFIZER COMMENTS: Although Pfizer can "do a large deal" if a transaction makes sense, "certain large companies have significant, almost binary risks ... which could immediately alter their values," so Pfizer will not rush into deals, Read stated on the company's first quarter results conference call yesterday. After Bristol-Myers' Opdivo drug failed to meet the endpoints of a trial in non-small cell lung cancer last year, the company does pose such risks, according to pharma news website FiercePharma. CUT TO SELL: BMO Capital analyst Alex Arfaei cut his rating on Bristol-Myers to Underperform from Market Perform. The analyst noted that he had previously written that the odds of the company being acquired are "reasonably low," partly due to "uncertainty" about its immuno-oncology franchise, including Opdivo. Read's comments echo those concerns, according to Arfaei. Moteover, later this year a number of events, including positive data for Merck's (MRK) immuno-oncology drug, Keytruda, will probably further cloud the future of Bristol Myers' IO portfolio, according to Arfaei. Uncertainty about ongoing tax reform initiatives in Washington also make an acquisition of Bristol Myers less likely, the analyst stated. PRICE ACTION: In morning trading, Bristol-Myers dropped 1.5% to $55.09 and Pfizer slid 0.6% to $33.42.
|
FB | Hot Stocks10:30 EDT Facebook to add 3,000 people over next year to review posts - Facebook plans to add 3,000 people over the next year to monitor reports of inappropriate material on the social media network such as videos of murders and suicides, CEO Mark Zuckerberg said in a Facebook post. Zuckerberg said the workers would be in addition to 4,500 people whom Facebook already has reviewing posts that may violate its terms of service. "These reviewers will also help us get better at removing things we don't allow on Facebook like hate speech and child exploitation. And we'll keep working with local community groups and law enforcement who are in the best position to help someone if they need it -- either because they're about to harm themselves, or because they're in danger from someone else. In addition to investing in more people, we're also building better tools to keep our community safe. We're going to make it simpler to report problems to us, faster for our reviewers to determine which posts violate our standards and easier for them to contact law enforcement if someone needs help. As these become available they should help make our community safer. This is important. Just last week, we got a report that someone on Live was considering suicide. We immediately reached out to law enforcement, and they were able to prevent him from hurting himself. In other cases, we weren't so fortunate. No one should be in this situation in the first place, but if they are, then we should build a safe community that gets them the help they need." Reference Link
|
S | Hot Stocks10:27 EDT Sprint CEO says 'lots of people calling' over last few days - Sprint CEO Marcelo Claure said on CNBC that "lots of people" have called over the past few days now that the quiet period from the spectrum auction has ended. Sprint will weigh its options, but operates as if it will remain a standalone company, Claure told viewers. He expects the next few weeks to be busy. Sprint shares are down 8%, or 71c, to $8.36 following the earnings report.
|
GRPN | Hot Stocks10:25 EDT Groupon says will be 'opportunistic' with share repurchases - Groupon is down over 14% to $3.43 in morning trading as conference call continues.
|
TSLA GLRE | Hot Stocks10:24 EDT Greenlight's Einhorn says Tesla investors 'remain hypnotized' by CEO Musk - On Greenlight RE's (GLRE) earnings call earlier, David Einhorn said about Tesla (TSLA), in which he holds a short position: "For the time being, investors remain hypnotized by Tesla's CEO. We're skeptical that the company will be able to mass market its Model 3 at volumes and margins that justify the current valuation." The Fly notes that these critical comments about Tesla made today by Einhorn echoes similar sentiments expressed in Greenlight Capital's recent quarterly letter to investors.
|
NVO | Hot Stocks10:18 EDT Novo Nordisk launches Xultophy 100/3.6 in the U.S. - Novo Nordisk announced the availability of its new combination therapy Xultophy 100/3.6 at pharmacies nationwide. Xultophy 100/3.6 combines long-acting basal insulin Tresiba with the #1 prescribed glucagon-like peptide-1 receptor agonist therapy Victoza in a single, once-daily injection. Xultophy 100/3.6 is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin or liraglutide.
|
CLRO | Hot Stocks10:16 EDT ClearOne awarded new patent for applied science - ClearOne has been awarded a patent for applied science that makes initial setup of its peerless Beamforming Microphone Array 2 quick and easy. The newly patented technology - featured on ClearOne's beamforming microphone arrays that incorporate orientation sensors - helps to ensure optimum performance for users.
|
IPCI | Hot Stocks10:03 EDT Intellipharmaceutics granted approval for ANDA for generic Seroquel XR - The FDA approval for the ANDA for Intellipharmaceutics' quetiapine fumarate 50mg was granted on May 1, according to a post to the FDA's website. Reference Link
|
DIS... | Hot Stocks09:57 EDT Hulu launches live TV service with over 50 channels for $39.99/month - Hulu, a joint venture of Disney (DIS), Comcast (CMCSA), Fox (FOXA) and Time Warner (TWX), announced the launch of the company's new live TV streaming beta service. The Hulu with Live TV (Beta) plan includes more than 50 sports, news, entertainment and kids' channels for $39.99 per month, the company said. In addition, the $39.99 per month base package includes Hulu's existing $7.99 premium streaming offering with limited commercials, which offers more than 3500 TV and film titles, the company added. Hulu also announced a new affiliate agreement with Scripps Networks Interactive (SNI) to bring its networks, including HGTV, Travel Channel and Food Network, to both Hulu's new live service and existing premium streaming offering.
|
PULM | Hot Stocks09:51 EDT Pulmatrix names Ted Raad as Chief Business Officer - Pulmatrix announced the appointment of Ted Raad as Chief Business Officer. In this newly created position, Raad will provide strategic business leadership as the company advances its programs through clinical development and partnership opportunities. Most recently, Raad was Chief Commercial Officer at Option Care.
|
SITO | Hot Stocks09:42 EDT SITO Mobile urges investors 'not to entrust their investment' to Baksa - SITO Mobile Ltd. said that its Board of Directors has mailed definitive consent revocation materials and issued a letter to its stockholders in connection with the pending solicitation of consents from SITO's stockholders by Stephen D. Baksa, Thomas Candelaria, Matthew Stecker, Thomas Thekkethala and the other participants in their solicitation seeking control of the SITO Board of Directors. SITO's letter outlines why SITO's stockholders should DISCARD any materials they might receive from the Baksa Group and NOT EXECUTE or return any gold consent cards that they might receive from the Baksa Group. In the letter, the SITO Board also urges stockholders not wishing to surrender control of SITO to the Baksa Group to execute and date each and every WHITE revocation card and return them as soon as possible to SITO. SITO believes that the "Karen Singer" who is viewed as an activist investor, and who has filed Schedule 13Ds with the SEC relating to at least nine different publicly-held companies, is actually a facade for Gary A. Singer, who is banned for life by the SEC from serving as an officer or director of a public company and who is rarely referenced in a Schedule 13D filed by Karen Singer, even though he seems to have a very visible, active and vocal role and appears to be the one orchestrating Karen Singer's activist campaign against SITO. SITO has never received any telephone calls or requests for meetings from Karen Singer, the individual who filed the Schedule 13D with the SEC relating to SITO, but only from her husband and son who specifically refer to themselves in their communications with SITO's management as "SITO's largest stockholder." SITO's Board of Directors strongly urges stockholders not to entrust their investment in SITO to the Baksa Group or the members thereof, such as Matthew Stecker and Thomas Thekkethala, who have ties to members of the Karen Singer family, including Gary A. Singer. Accordingly, to protect your investment in SITO, you are urged to NOT execute any gold consent card and to DISCARD all materials sent to you by the Baksa Group or any member of the Karen Singer family who may seek to influence your vote in the consent solicitation.
|
DHX | Hot Stocks09:35 EDT DHI Group trading resumes
|
DHX | Hot Stocks09:32 EDT DHI Group trading halted, news dissemination
|
HOPE | Hot Stocks09:31 EDT Hope Bancorp extends employment agreement of CEO Kevin Kim - Hope Bancorp announced that its board has entered into an amended and restated employment agreement with president and CEO Kevin Kim extending his tenure through March 31, 2022.
|
NYMX | Hot Stocks09:31 EDT Nymox files for marketing approval for Fexapotide Triflutate in Europe - Nymox is pleased to announce today that the company has filed to seek approval for marketing authorization for Fexapotide Triflutate in five European countries, comprising the Netherlands, the UK, Germany, France and Spain. This first filing for Fexapotide Triflutate is for the indication of treatment of the symptoms of BPH.
|
HUM | Hot Stocks09:30 EDT Humana says 'selectively looking at' group MA opportunities
|
GSAT... | Hot Stocks09:30 EDT Globalstar rises after Straight Path discloses sweetened bid from suitor - Shares of Straight Path Communications (STRP) have jumped 23% after disclosing that a "multi-national telecommunications company" has raised its bid to acquire 100% to company for $135.96 per share, reflecting an enterprise value of approximately $2.3B. Peer Globalstar (GSAT) is also up 7c, 3.7%, to $1.97 in pre-market trading after Straight Path called the new sweetened bid a "superior proposal" to the terms of its agreement and plan of merger with AT&T (T).
|
MDLZ... | Hot Stocks09:30 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: First Solar (FSLR), up 7.2%... Mondelez (MDLZ), up 3%... FireEye (FEYE), up 13.4%... Carlyle Group (CG), up 4%... Delphi Automotive (DLPH), up 6.4% after reporting quarterly results and announcing the planned spin-off of its Powertrain unit... Weight Watchers (WTW), up 14.7%... Paycom (PAYC), up 3.3%... Myriad Genetics (MYGN), up 11.1%... Yum! Brands (YUM), up 1.3%... Berry Plastics (BERY), up 1.7%... New York Times (NYT), up 3.2%... CommVault (CVLT), up 10.6%. ALSO HIGHER: Straight Path (STRP), up 23.2% after announcing that a mult-national telecom made a $2.3B proposal that is superior to AT&T's (T) offer to acquire the company... AT&T is up fractionally... Array Biopharma (ARRY), up 6% after being upgraded to Overweight from Neutral at JPMorgan... Pieris Pharmaceuticals (PIRS), up 39.2% after entering a collaboration with AstraZeneca (AZN). DOWN AFTER EARNINGS: Apple (AAPL), down 1.1%... Sprint (S), down 1.3%... Groupon (GRPN), down 13.3%... Molson Coors (TAP), down 3.1%... ADP (ADP), down 4.8%... Twilio (TWLO), down 28%... Akamai (AKAM), down 12.9%... Etsy (ETSY), down 11.3%... Frontier Communications (FTR), down 8.3%... Bunge (BG), down 7.7%... Cray (CRAY), down 11.1%... Anadarko Petroleum (APC), down 6.9%. ALSO LOWER: Perrigo (PRGO), down 4.8% after disclosing a federal investigation into drug pricing.
|
AZN PIRS | Hot Stocks09:23 EDT AstraZeneca to make $57.5M-$45M of upfront payments to Pieris Pharmaceuticals - AstraZeneca will make an upfront and near term milestone payments to Pieris in the amount of $57.5M-$45M of upfront payments and $12.5M for the initiation of the PRS-060 Phase 1 trial. Pieris has the potential to receive development-dependent milestones and eventual commercial payments for all products not exceeding $2.1B as well as tiered royalties on the sales of any potential products commercialized by AstraZeneca. For programs co-developed by Pieris, the Company stands to receive increased royalties or a gross margin share on worldwide sales equal, dependent on the level of investment to which Pieris commits.
|
HUM | Hot Stocks09:22 EDT Humana says 'very committed' to Humana at Home
|
VRTU C | Hot Stocks09:20 EDT Virtusa names Vikram Pandit to board - Pandit is the former CEO of Citigroup and is currently chairman and CEO of The Orogen Group.
|
S | Hot Stocks09:19 EDT Sprint says 'not in rush' for M&A opportunities - Says the company is "self sufficient."
|
VRTU | Hot Stocks09:19 EDT Virtusa board authorizes $30M share repurchase program - Virtusa's Board of Directors has authorized a share repurchase program of up to $30 million of Virtusa's common stock over the next twelve months. The Company will fund share repurchases with the proceeds of the Orogen investment and cash on hand. Share repurchases under the program may be made through open market purchases or privately negotiated transactions in accordance with applicable federal securities laws, including Rule 10b-18 of the Exchange Act of 1934. While the Board of Directors has approved the share repurchase plan, the timing of repurchases and the exact number of shares of common stock to be purchased will be determined by Virtusa management, at its discretion, and will depend upon market conditions and other factors.
|
VRTU | Hot Stocks09:18 EDT Virtusa announces $108M strategic equity investment from Orogen Group - Virtusa Corporation announced that it has entered into an Investment Agreement under which The Orogen Group purchased shares of the company's newly issued Convertible Preferred Stock, initially convertible into 3,000,000 shares of common stock, for an aggregate purchase price of $108M. In connection with the investment, Vikram Pandit has been appointed to Virtusa's Board of Directors. Orogen is a new operating company that was created by Vikram Pandit and Atairos Group, Inc., an independent private company focused on supporting growth-oriented businesses, to leverage the opportunities created by the evolution of the financial services landscape and to identify and invest in financial services companies and related businesses with proven business models. Virtusa intends to use the proceeds from the sale of its Convertible Preferred Stock to repay approximately $81M of its senior term loan, as well as for common stock repurchases and general corporate purposes. Virtusa's Board has approved the repurchase of approximately $30M of common stock.
|
NKTR | Hot Stocks09:18 EDT Nektar names Brian L. Kotzin as Head of Clinical Development - Nektar Therapeutics appointed Brian Kotzin as Head of Clinical Development for Nektar's Immunology Program. In this newly-created role, Kotzin will lead clinical development for NKTR-358, a first-in-class regulatory T cell stimulator, being developed for the treatment of immune and inflammatory disorders. From 2004 to 2015, Dr. Kotzin was previously at Amgen, where he served as Vice President, Global and Clinical Development and Head, Inflammation Therapeutic Area, directing the global development efforts for Amgen product candidates in the inflammation area.
|
MSFG | Hot Stocks09:17 EDT MainSource Financial's Chief Credit Officer Bill Goodwin retiring - MainSource Financial announced the retirement of William J. Goodwin, Chief Credit Officer, effective May 3. He joined MainSource Bank in 2009.
|
YUM | Hot Stocks09:15 EDT Yum! Brands sees FY17 global SSS growth of 2%-3%
|
HUM | Hot Stocks09:14 EDT Humana sees long-term annual EPS growth of 11%-15% - Says early metrics indicate "strong" start to 2017. Sees quarterly EPS progression reflecting just under 30% of the FY number in each of the second and third quarters. Says Q4 to reflect "the usual cost increases associated with the open enrollment season." Says has lowered expectations around 2017 individual MA membership growth to 15,000-25,000 from 30,000-40,000, increasing group MA membership by 10,000 members to 80,000-90,000. Says does not expect these changes to impact overall Medicare profitability. Says group and specialty segment performance running in line with expectations. Sees long-term annual EPS growth of 11%-15%, with annual results varying; Humana last week guided long-term annual EPS growth of low-to-mid teens at its investor conference. Comments taken from the Q1 earnings conference call.
|
SNPS | Hot Stocks09:14 EDT Synopsys and InfoSec Global partner for Root of Trust solution - Synopsys and InfoSec Global are collaborating to provide a comprehensive, embedded Root of Trust solution that integrates InfoSec Global's Agile Cryptography capabilities with Synopsys' DesignWare tRoot Hardware Secure Module. The combined solution will provide designers with the programming interfaces needed to customize and differentiate their system-on-chips for highly secure industrial IoT applications such as programmable logic controllers, Supervisory Control and Data Acquisition and Distributive Control Systems.
|
ILG | Hot Stocks09:11 EDT ILG's Interval signs club affiliation agreement with Hope Club International - Interval International, an operating business of ILG, and Chengdu Homeland Hotel Management, a division of Continental Hope Group, announced an exclusive, multiyear club affiliation agreement. The contract includes units housed in Homeland International Hotel in southwest China's Chengdu city and Mumian Lake Homeland Resort on Hainan Island in southeast China. Both are part of the recently launched Hope Club International, the Continental Hope Group's entry into shared ownership. "We are extremely pleased to welcome this very successful and well-respected hospitality company to the industry. Its club offers owners and guests the opportunity to enjoy a quality vacation experience in a historic urban location or a beach retreat in a highly demanded destination," said David Gilbert, Interval's president. "We understand that there is an increase in travel to China, as well as more and more residents traveling within the country, and these trends bode well for Hope Club."
|
S | Hot Stocks09:10 EDT Sprint says CapEx to remain at $3.5B-$4B over next three years - Says plans to optimize channel mix and distribution. Says would rather focus on network than buying additional spectrum.
|
WCST | Hot Stocks09:09 EDT Wecast Network appoints Grant Thornton as new independent auditor - Wecast Network announced a change to the vompany's independent registered public accounting firm. Grant Thornton LLP will succeed KPMG Huazhen as the company's independent public accounting firm and Grant Thornton will review the company's financial statements for the quarter ending March 31, subsequent quarters in 2017 and the year ending audit for the 12 months ended December 31 and beyond. In connection with the audits of the company's financial statements for each of the two fiscal years ended December 31, 2016 and 2015, and in the subsequent interim period from January 1, 2017 through April 27, 2017, there were no disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference in in connection with their opinion to the subject matter of the disagreement.
|
CNDT | Hot Stocks09:08 EDT Greenlight Capital on call announces investment in Conduent
|
TWX | Hot Stocks09:06 EDT Time Warner sees Turner seeing biggest impact from new NBA pact in Q2 - CFO Howard Averill said Turner will see the biggest impact related to its new contract with the NBA in the second quarter, which he expects to contribute to total programming cost growth of approximately 20%.
|
PFE | Hot Stocks09:05 EDT Pfizer announces FDA filing acceptance of sNDA for Xeljanz - Pfizer announced that the FDA has accepted for review the supplemental New Drug Application for Xeljanz 5 mg twice daily for the treatment of adult patients with active psoriatic arthritis. A separate sNDA was also accepted for Xeljanz XR extended release 11 mg once daily use in PsA. The sNDA submission is based on data from the Phase 3 Oral Psoriatic Arthritis Trials clinical development program, which consisted of two pivotal trials and a long-term extension study, evaluating the safety and efficacy of Xeljanz in patients with active PsA who had failed prior PsA treatments. The FDA has provided an anticipated Prescription Drug User Fee Act action date in December for the sNDAs. Two pivotal Phase 3 studies were included in the submission package. OPAL Broaden was conducted in conventional synthetic disease-modifying antirheumatic drug inadequate response and tumor necrosis factor inhibitor-naive patient populations. The study included an active control arm of adalimumab. However, the study was not designed for non-inferiority or superiority comparisons between adalimumab and Xeljanz. OPAL Beyond was conducted in TNFi-IR patients and was the first PsA study focused exclusively in this population. Both studies met their primary efficacy endpoints showing a statistically significant improvement with Xeljanz 5 mg and 10 mg BID compared to treatment with placebo at three months as measured by American College of Rheumatology 20 response and change from baseline in Health Assessment Questionnaire Disability Index score. In both studies adverse events were more frequent with Xeljanz 5 mg and 10 mg BID versus placebo. Overall safety findings were consistent with those observed in the broader rheumatology clinical development program for Xeljanz. Interim results from OPAL Balance, the long-term extension study of Xeljanz in patients with active PsA, were also included in the submission package.
|
AJG | Hot Stocks09:05 EDT Arthur J. Gallagher acquires Texas Insurance Managers - Arthur J. Gallagher acquired Harlingen, Texas-based Texas Insurance Managers. Terms of the transaction were not disclosed. Texas Insurance Managers offers commercial and personal property/casualty, life/health, retirement and employee benefit services to clients primarily in South Texas. Richard May, Josh Klostermann, Ryan Newman and their associates will continue to operate from their current location under the direction of Bret VanderVoort, head of Gallagher's South Central retail property/casualty brokerage operations.
|
MGM | Hot Stocks09:03 EDT MGM Resorts and GVC partner for online gaming in New Jersey - MGM Resorts and multinational sports betting and gaming group GVC Holdings have entered into an agreement to launch online casino and poker games in New Jersey under the playMGM brand. GVC currently provides software and support services for the MGM Resorts-owned Borgata Hotel Casino & Spa in New Jersey. Launching later this year, playMGM casino and poker will sit on the latest version of GVC's proprietary technology stack. playMGM customers are also set to benefit from MGM Resorts' M life Rewards program, which will be integrated into the GVC platform.
|
GIS | Hot Stocks09:03 EDT General Mills say Powell to retire, names COO Harmening as new CEO - General Mills announced that its board of directors has elected Jeffrey Harmening as Chief Executive Officer of the company, effective June 1. The board also elected Harmening to the General Mills board of directors. Harmening has served as President and Chief Operating Officer since July 1, 2016. Harmening succeeds Ken Powell, who has served as General Mills Chairman and CEO since 2007. Powell will continue to serve as the company's Chairman for a transition period until his retirement, expected within the next year.
|
YUM | Hot Stocks09:03 EDT Yum! Brands says sees EPS of $3.75 by 2019
|
S | Hot Stocks09:03 EDT Sprint says sees FY17 adjusted free cash flow down y/y
|
STRP... | Hot Stocks09:02 EDT AT&T on the clock with Straight Path trading well above new buyout offer - Straight Path Communications (STRP) said earlier that it notified AT&T (T) of its board's determination of a superior takeover offer from a "multi-national telecommunications company". Pursuant to the current merger agreement, AT&T has the option for the next three business days to negotiate a possible amendment of its agreement to match or exceed the competing bidder's offer. Straight Path announced this morning that its board determined that a revised offer from a multi-national telecommunications company to acquire 100% of its issued and outstanding shares for $135.96 per share is superior to AT&T's current offer. The unnamed bidder has been reported to be Verizon Communications. Shares of Straight Path are well above the new $135.96 offer in premarket trading. The stock is up 23%, or $29.18, to $155.00.
|
SKX | Hot Stocks09:02 EDT Skechers announces global marketing campaign with David Ortiz - SKECHERS announces that ten-time All-Star Dominican-American baseball slugger David Ortiz will be lacing up in SKECHERS Men's footwear for a multi-platform global marketing campaign set to launch this Fall.
|
AMZN GOOG | Hot Stocks09:01 EDT Amazon says FreeTime now available on Android phones, tablets - Amazon (AMZN) announced that kids can now enjoy the Amazon FreeTime Unlimited service, including books, videos, YouTube videos and websites on Android (GOOG) phones and tablets. The FreeTime app for Android is free to use and offers similar parental controls that are available with FreeTime on Fire Tablets, including Fire Kids Edition, plus access to over 40,000 YouTube videos and websites that have been hand-selected by the FreeTime team. For even more content, parents can add the Amazon FreeTime Unlimited service starting at $2.99 per month to gain unlimited access to over 10,000 age-appropriate books and videos. Parents can download the FreeTime app starting today. "Over 10 million kids have enjoyed Amazon FreeTime on Fire Tablets, Kindle e-Readers, and Amazon Fire TV-we're thrilled to bring that same award-winning experience to even more families," said Kurt Beidler, Director of Kids & Family, Amazon.
|
TWX | Hot Stocks08:59 EDT Time Warner 'very confident' in high single digit HBO subscription growth view - Time Warner CFO Howard Averill noted that HBO subscription revenues increased 5% in the quarter, which he said was "right in line with our expectations." Averill said that, looking ahead, the company is seeing better subscriber performance at its traditional distributors as it begins to benefit from new affiliate deals and expects that to continue improving throughout the year. "When combined with continues healthy growth for our OTT products and solid international trends, we expect subscription revenue growth to accelerate into the high single digits in the second quarter and to remain strong throughout the year. So we're very confident in delivering the high single digit growth for the year that we previously discussed," Averill added on the company's Q1 earnings call.
|
S | Hot Stocks08:57 EDT Sprint says has 'good momentum' in cost transformation
|
CTXS CG | Hot Stocks08:54 EDT Citrix rises after Bloomberg reports bids from multiple suitors - Shares of Citrix Systems (CTXS) are rising in pre-market trading after Bloomberg reported last night that Bain Capital, Carlyle Group (CG) and Thoma Bravo are among the private equity firms that submitted bids to buy the company last week. Citrix has also attracted interest from at least one strategic suitor, though the identity of that potential buyer could not be learned by the people who spoke to Bloomberg, the news service stated in its report. After the report, Citrix shares are up $5.44, or 6.7%, to $86.73 in pre-market trading. Reference Link
|
S | Hot Stocks08:51 EDT Sprint unveils Sprint Magic Box all-wireless small cell - Sprint unveiled the Sprint Magic Box, an all-wireless small cell. Sprint Magic Box is a new plug-and-play LTE small cell for businesses and consumers that dramatically improves data coverage and increases download and upload speeds on average by 200%. The new technology allows Sprint to very quickly and cost-effectively densify its nationwide LTE Plus network, and provide an improved experience for its millions of customers today and in the future. Sprint Magic Box is free to use for qualifying businesses and consumers.
|
LH | Hot Stocks08:50 EDT LabCorp adds new test panels to VistaSeq Hereditary Cancer portfolio - LabCorp announced a significant enhancement to its proprietary VistaSeq Hereditary Cancer portfolio, with ten new test panels focusing on the risk of specific hereditary cancer syndromes. The number of cancer genes that can be assessed has also increased to 59 to reflect advances in the understanding of cancer genetics since the panel was first introduced in August 2015. The VistaSeq Hereditary Cancer Panel detects inherited genetic mutations across multiple genes, which have been associated with an increased risk of developing hereditary cancers. The tests are available from LabCorp and its Integrated Genetics and Integrated Oncology specialty laboratories. The VistaSeq Hereditary Cancer Panel provides an assessment of the genetic mutations known to be associated with the most common hereditary cancers including breast, ovarian, melanoma, pancreatic, colorectal, endometrial, gastric, and prostate cancers. The new panels, along with the increase in the cancer-linked genes that can be assessed, enable physicians to select the panel that best meets the needs of each patient based on their personal or family history. The VistaSeq Hereditary Cancer Panel is available nationwide through any LabCorp, Integrated Genetics or Integrated Oncology account.
|
FNLC | Hot Stocks08:48 EDT The First Bancorp says was 'incorrectly identified' in press release - In a press release issued on May 2 by WeissLaw LLP, the trading symbol of The First Bancorp, a Maine-based company, was incorrectly included. The WeissLaw LLP press release stated that the law firm is investigating issues related to a proposed transaction between two North-Carolina-based bank holding companies that was announced on May 1. The First Bancorp is not involved in the proposed transaction in any way and has requested the WeissLaw LLP press release be retracted.
|
S | Hot Stocks08:48 EDT Sprint says Magic Box will provide both indoor and outdoor network coverage
|
AER... | Hot Stocks08:47 EDT Aercap signs lease agreement with Austrian Airlines for Boeing 777 aircraft - AerCap Holdings (AER) announced it has signed a lease agreement for a Boeing (BA) 777-200ER with Austrian Airlines. The aircraft is scheduled to deliver in January 2018. Manufactured in 2001, the aircraft was operated by Aeromexico (GRPAF). AerCap President and CCO Philip Scruggs said, "The 777 remains a work-horse of the industry. This transaction proves the continued demand for the aircraft type. We have leased 777-200ER to both scheduled flag carriers and leisure operators. The combination of size and performance makes the 777-200ER an ideal aircraft for Austrian Airlines' fleet requirements."
|
GRPN | Hot Stocks08:47 EDT Groupon says 'no changes' to FY guidance ranges - Says international turnaround likely to take a few more quarters than expected. Sees "greater potential to end up toward the low end of our $1.30B-$1.35B gross profit range." Comments from slides that will be presented on the Q1 earnings conference call. Groupon is down nearly 11% in pre-market trading.
|
SPA | Hot Stocks08:43 EDT Sparton, Ultra Electronics USSI JV awarded $17.4M in foreign sales contracts - Sparton Corporation and Ultra Electronics USSI, a subsidiary of Ultra Electronics Holdings, announced the award of subcontracts valued at $17.4M from their ERAPSCO/SonobuoyTech Systems joint venture. ERAPSCO/SonobuoyTech Systems will provide manufacturing subcontracts in the amount of $11.2M to Ultra Electronics USSI and $6.2M to Sparton De Leon Springs. Production will take place at Ultra Electronics USSI's Columbia City, Indiana facility and Sparton's De Leon Springs, Florida facility. ERAPSCO/SonobuoyTech Systems were awarded multiple foreign contracts for the manufacture of Passive and Active sonobuoys in support of multiple underwater missions for detection, classification, and localization of adversary submarines during peacetime and combat operations.
|
TWX T | Hot Stocks08:43 EDT Bewkes says 'increasingly excited' to accelerate innovation with AT&T - Time Warner CEO Jeff Bewkes continues speaking on the company's earning call.
|
YUM | Hot Stocks08:42 EDT Yum! Brands says investing $130M to upgrade Pizza Hut in U.S. - Says investments will be in digital operations, technology.
|
S | Hot Stocks08:41 EDT Sprint says will relaunch Virgin Mobile brand in 2017
|
GRPN | Hot Stocks08:41 EDT Groupon drops in pre-market trading after Q1 revenue misses estimates - Groupon shares are down 50c, or 12.5%, to $3.50 in pre-market trading following the company's Q1 report.
|
YUM | Hot Stocks08:41 EDT Yum! Brands sees returning $6.5B-$7B to shareholders over next three years - Says on track for 2019 goals, including reducing G&A to 1.7% of system sales, free cash flow conversion to 100%, franchise mix of at least 98%.
|
ARNC | Hot Stocks08:39 EDT Elliott releases new video on Arconic called 'Meet the Shareholder Nominees' - Elliott Management Corporation, which manages funds that collectively beneficially own a 13.2% economic interest in Arconic, released a new video on NewArconic.com titled "Meet the Shareholder Nominees." The new video shows that while questions about the Company's slate continue to linger, the independence, qualifications, and operating experience of the nominees put forward by Elliott ae beyond debate. Specifically: The Shareholder Nominees possess deep industry knowledge and extensive operating experience. The Shareholder Nominees are completely independent - they will have no ties with Elliott. The Shareholder Nominees would add a combined 80 years of industry experience (including at the Company and its closest competitor, Precision Castparts Corporation) to the Arconic Board. One of the Shareholder Nominees is a former industrial and materials executive who has run multiple CEO searches. The Shareholder Nominees would be ready on day one to start creating value for shareholders as constructive members of the Arconic Board.
|
S | Hot Stocks08:39 EDT Sprint says introducing 'Magic Box' indoor LTE network antenna - Comments from Q4 earnings conference call.
|
STRS | Hot Stocks08:39 EDT Stratus Properties obtains $26.3M in financing for Latana Place developmentNewPage - Stratus Properties announced that it has obtained a $26.3M construction loan from Southside Bank to finance construction of the initial phase of Stratus' Lantana Place mixed-use development project in Austin, Texas. Lantana Place will be developed in two phases totaling approximately 325,000 square feet of retail, hotel and office uses. Lantana Place is fully designed and permitted and Stratus expects to break ground on the first phase of the project in May.
|
TWX | Hot Stocks08:38 EDT Time Warner CEO says Q1 results set company up 'very well' to reach FY goals - Time Warner CEO Jeff Bewkes is speaking on the company's earning call.
|
TRPX GLMD | Hot Stocks08:37 EDT Therapix Biosciences appoints Josh Blacher as CFO - Therapix Biosciences (TRPX) has appointed Josh Blacher as CFO. Prior to joining Therapix, Blacher served as CFO at Galmed Pharmaceuticals (GLMD). Previously, Blacher also held senior positions in licensing and investing at Teva Pharmaceuticals.
|
BERY | Hot Stocks08:35 EDT Berry Plastics raises annual cost synergy target for AEP acquisition to $70M - "Looking ahead, we will continue our focus on reducing our leverage ratio to a goal of below 4, on or before the end of fiscal 2017. Additionally, we remain excited about our recent acquisition of AEP, and the results to date have validated our expectations of the synergy potential and scale advantages through the combined businesses. Based on our progress to date, we are increasing our annual cost synergy target for the AEP acquisition from our initial $50 million to $70 million. Throughout the remainder of the year we will continue to work on further cost reduction opportunities," stated the company. "Today, we are also reaffirming our fiscal year 2017 projected cash flow from operations of $925 million and adjusted free cash flow of $550 million. These estimates include the recent acquisition of AEP completed on January 20, 2017, the $60 million tax receivable payment that was made in the first fiscal quarter and assumes net capital expenditures of $315 million. Additionally, our cash interest expense is forecasted to be $275 million for fiscal 2017. Within our guidance, we are also assuming $80 million of cash used for other taxes, primarily related to state and international jurisdictions, and other cash uses of $60 million related to items such as acquisition integration expenses and costs to achieve synergies.
|
ALGN | Hot Stocks08:35 EDT Align Technology announces $50M accelerated stock repurchase agreement - Align Technology announced that it has entered into an accelerated stock repurchase agreement, or ASR, with Wells Fargo Bank to repurchase $50M of Align's common stock as part of Align's, $300M stock repurchase program announced on April 28, 2016. Under the terms of the ASR, Align has agreed to repurchase $50M of its common stock through Wells Fargo, with an initial delivery of approximately 261,000 shares.
|
BAX | Hot Stocks08:34 EDT Baxter recieves FDA guidance for peritoneal dialysis technology - Baxter International received guidance from the FDA clarifying the regulatory pathway for an innovative, home peritoneal dialysis solution system to improve patient access to home dialysis. The new system is designed to produce sterile PD solutions using a small water filtration device that would be placed in the patient's home and integrated with Baxter's unique AMIA automated peritoneal dialysis system with SHARESOURCE telehealth platform. Following FDA guidance, Baxter's PD solution generation system will follow a regulatory pathway as a combination product, which is the process the agency uses for products that include a device and pharmaceutical component. Baxter plans to have the first patient on therapy with the new system, as part of a clinical trial in 2018. Regulatory submission is expected in 2019. PD is a self-administered therapy managed at home by end-stage renal disease patients. The therapy works inside the body, using the abdominal lining as a natural filter to remove toxins from the bloodstream. PD solution dwells in the cavity before draining. The process then repeats itself three to four times during each therapy session. Solutions with higher concentrations of dextrose are sometimes used to remove higher amounts of fluid and waste that can be pulled from the body. Baxter's PD solution generation technology is designed to integrate with AMIA and SHARESOURCE, and allow a physician to tailor the treatment regimen for each patient. Baxter's new system would provide physicians the flexibility to prescribe different dextrose concentrations for each dwell cycle, depending on each patient's needs. Baxter's on-demand solution technology is an investigative product and not approved for use. AMIA with SHARESOURCE is by Rx Only.
|
NYT | Hot Stocks08:33 EDT New York Times sees FY17 CapEx $85M-$90M - The Company expects the following on a pre-tax basis in 2017: Depreciation and amortization: $60 million to $65 million, Interest expense, net: $20 million to $25 million, and Capital expenditures: $85 million to $90 million.
|
NYT | Hot Stocks08:32 EDT New York Times sees Q2 circulation revenues up at rate similar to Q1 - Total circulation revenues in the second quarter of 2017 are expected to increase at a rate similar to that of the first quarter of 2017. Growth in the number of paid digital-only subscriptions to our news products in the second quarter of 2017 is expected to be slower than the prior two quarters. Total advertising revenues in the second quarter of 2017 are expected to decrease in the low- to mid-single digits compared to the second quarter of 2016. Operating costs and adjusted operating costs are expected to increase in the mid-single digits in the second quarter of 2017 compared with the second quarter of 2016.
|
ALOT | Hot Stocks08:31 EDT Astro-Med announces repurchase of 826,305 shares of common stock - AstroNova announced that it has repurchased 826,305 shares of its common stock from the Albert W. Ondis Declaration of Trust for $11.2 million, or $13.60 per share. The repurchased shares constituted approximately 12.7% of the outstanding shares of AstroNova's common stock. The transaction was executed on May 1, 2017 and was funded May 2, 2017 using existing cash on hand. Following the repurchase, the Trust owns 36,000 shares of the Company's common stock, or approximately 0.5% of the total number of outstanding shares of common stock.
|
YUM | Hot Stocks08:29 EDT Yum! Brands says Taco Bell on pace for positive SSS this year
|
YUM | Hot Stocks08:29 EDT Yum! Brands to host 'brand days' in place of annual investor and analyst meeting
|
YUM | Hot Stocks08:28 EDT Yum! Brands says plans to expand delivery 'rapidly' for KFC International
|
YUM | Hot Stocks08:22 EDT Yum! Brands backs FY guidance of mid single digit core operating profit growth - CEO Greg Creed says the company is backing its FY guidance of mid single digit core operating profit growth, which assumes high single digit underlying base operating profit growth, offset by 1.5 percentage point 53rd week headwind and another 1-2 percentage point headwind from the net timing impact of refranchising and associated G&A reductions. Says on track with refranchising, cost savings efforts. Comments taken from the Q1 earnings conference call.
|
ISR | Hot Stocks08:13 EDT IsoRay's Cesium-131 for prostate brachytherapy featured in published study - IsoRay announced the acceptance for publication of a study entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131" in the International Journal of Radiation Oncology, Biology, Physics. The aim of the study was the evaluation of long-term quality of life as reported by men treated at UPMC with Cesium-131 prostate brachytherapy. The study's authors concluded that at last follow-up, there were no clinically significant changes found in the EPIC scores from baseline, demonstrating insignificant long-term changes in urinary or bowel patient-reported quality of life with Cesium-131 prostate brachytherapy. The report concludes that patients treated with Cesium-131 are able to recover from prostate cancer treatment quickly and then maintain their baseline quality of life over the long term.
|
LMNX | Hot Stocks08:08 EDT Luminex receives FDA clearance for ARIES Bordetella Assay - Luminex announced that it has received FDA clearance for the ARIES Bordetella Assay for direct detection and identification of Bordetella pertussis and Bordetella parapertussis nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to B. pertussis or B. parapertussis. This is the fourth assay the FDA has cleared since October 2015 for use on Luminex's ARIES Systems. The company has also achieved CE-IVD marking for the ARIES Bordetella Assay, is preparing to submit its Clostridium difficile assay to the FDA later this month, and is in the process of completing a Group A Streptococcus clinical trial as it seeks to further expand its ARIES menu.
|
ADK | Hot Stocks08:07 EDT AdCare completes purchase of Alabama facility for $5.5M - AdCare Health announced it completed the purchase of an assisted living and memory care facility with 106 operational beds located in Alabama for $5.5M on May 1. The company also announced the commencement of a long-term lease to operate the facility to an affiliate of C.Ross Management, LLC. C.Ross, AdCare's largest operator, operates 22 facilities in Georgia and Alabama through its affiliates. The terms of the long-term lease agreement, include a 13-year term with initial annual cash rent of $450,000 in the first year and a 2% annual rent escalator.
|
BOLD | Hot Stocks08:05 EDT Audentes Therapeutics to present data on candidates AT132 and AT342 - Audentes Therapeutics announced that data related to its product candidates AT132 for the treatment of X-linked Myotubular Myopathy, and AT342 for the treatment of Crigler Najjar Syndrome, will be presented at the 20th Annual Meeting of the American Society of Gene and Cell Therapy to be held in Washington, DC on May 10-13th, 2017. Four abstracts will be presented during the meeting. John T. Gray, Ph.D, Senior Vice President, Research and Development, commented, "We plan to initiate Phase 1/2 clinical studies of both in mid-2017, and to report preliminary results from each program by year-end."
|
AHT... | Hot Stocks08:04 EDT Ashford Hospitality announces withdrawal of Felcor Lodging merger proposal - Ashford Hospitality Trust (AHT) announced that given FelCor Lodging Trust's (FCH) announced merger agreement with RLJ Lodging Trust (RLJ), Ashford Trust is abandoning its efforts to merge with FelCor. Ashford Trust also announced that it is withdrawing its preliminary proxy statement and proposed slate of seven independent directors for election to FelCor's Board of Directors at FelCor's 2017 Annual Meeting of Stockholders. While Ashford Trust continues to believe that its offer would have been more attractive to shareholders than the RLJ offer, the Company has determined that there is no cost-effective, actionable path forward toward an agreement and has withdrawn its non-binding proposal. The Company believes that it exercised significant strategic and financial discipline in seeking ways to maximize shareholder value. The company plans to opportunistically liquidate its investment in FelCor stock over time.
|
EIGR | Hot Stocks08:03 EDT Eiger BioPharmaceuticals files Pegylated Interferon Lambda IND for HDV infection - Eiger BioPharmaceuticals has filed the U.S. IND for Pegylated Interferon Lambda in the treatment of hepatitis delta virus infection. U.S. sites are planned for the ongoing Phase 2 LIMT HDV study, a monotherapy trial of pegylated interferon lambda 1a as a potential treatment for chronic hepatitis D virus infection.
|
AMMA | Hot Stocks08:01 EDT Alliance MMA acquires assets of NFC; financial terms not disclosed - Alliance MMA announced that it has acquired the assets of National Fighting Championship, which produces professional regional MMA events throughout Georgia and South Carolina. NFC will be the 9th regional MMA promotion operating under the Alliance MMA umbrella.
|
W | Hot Stocks07:46 EDT Wayfair expands outdoor offerings, offers one and two-day shipping - Wayfair announced the expansion of its outdoor offering at Wayfair.com to include an unparalleled selection of dining sets, fire pits, hammocks and storage sheds as well as thousands of exterior home renovation products such as outdoor lighting and outdoor flooring and tile. In addition, Wayfair has also broadened its Custom Outdoor Cushion program with more than 50 fabrics including over 35 Sunbrella options spanning a variety of styles. "With one and two-day shipping on thousands of outdoor items, it is now faster than ever before for Wayfair shoppers to create and furnish spaces for outdoor living," the company said.
|
ICE | Hot Stocks07:45 EDT IntercontinentalExchange reports April ICE ADV up 26% y/y - Reports ICE ADV up 26% y/y, driven by Financials ADV up 62% y/y and Commodities ADV up 7% y/y.
|
SPR | Hot Stocks07:40 EDT Spirit says on track to ramp up production rate on Boeing 737 to 47/month - "We are on track to ramp up the production rate on the Boeing 737 program from 42 airplanes per month to 47 per month before the end of the second quarter and increase the A350 production rate to 10 per month by 2018," Spirit President and CEO Tom Gentile said.
|
ICE | Hot Stocks07:38 EDT IntercontinentalExchange sees Q2 GAAP operating expenses $550M-$560M - ICE's second quarter 2017 GAAP operating expenses are expected to be in a range of $550 million to $560 million and adjusted operating expenses are expected to be in a range of $485 million to $495 million. ICE's diluted share count for the second quarter and full year 2017 is expected to be in the range of 590 million to 600 million weighted average shares outstanding.
|
S | Hot Stocks07:37 EDT Sprint says will announce 'exciting technology innovation' on earnings call - In its earnings press release, Sprint stated: "As previously announced, Sprint helped develop a breakthrough innovation called High Performance User Equipment - HPUE - a new technology that extends the coverage of its 2.5GHz spectrum by up to 30 percent to nearly match its mid-band 1.9GHz spectrum performance on capable devices. In one of the fastest progressions from global standard approval to commercial availability, HPUE-capable devices are already available to Sprint customers, including the recently launched LG G6, Samsung Galaxy S8, and ZTE Max XL. The company will be announcing another exciting technology innovation on today's conference call."
|
CLH | Hot Stocks07:36 EDT Clean Harbors continues to see FY17 adjusted EBITDA $435M-$475M - "As we move into our seasonally stronger periods of the year, we expect momentum to accelerate across several key markets, particularly those related to our Technical Services and Safety-Kleen segments," McKim said. "After a sluggish first quarter, both U.S. Industrial Production and GDP are expected to pick up as the year advances, which should drive additional waste volumes into our network. This conclusion is supported by a noticeable uptick in customer activity and sales opportunities. With crude oil prices having stabilized in recent months, customers in multiple industries have been more confident in their spending decisions. In addition, the energy market itself has strengthened, with increases in rig counts and overall activity. Base oil and lubricant prices have risen steadily - a positive development as we move toward the summer driving season. "With our new El Dorado incinerator now successfully launched and fully operational, we are ready to capitalize on an improving economic outlook and opportunities for increased waste volumes, particularly as the Chemical sector begins to rebound from its slowdown this past year. Within Safety-Kleen, we are confident that our closed-loop offering will grow incrementally throughout 2017, as we broaden the bulk lubricants delivery of our Performance Plus brands to additional metropolitan areas. Our Safety-Kleen branches continue to expand, aided by the acquisitions we made in 2016. Finally, our focus on profitable growth and margin expansion in 2017 will be supported by our comprehensive and ongoing cost-reduction efforts," McKim concluded. On a GAAP basis, the Company's guidance is based on 2017 net income in the range of $4 million to $35 million. Adjusted net income for 2017, which includes the recognition of the non-cash tax benefits in Canada and valuation allowances, is in the range of $24 million to $48 million.
|
SBGI | Hot Stocks07:35 EDT Sinclair Broadcast sees FY17 CapEx $90M - Excluding capital expenditures that may be incurred for the FCC's spectrum repack. The Company's effective tax rate is expected to be approximately 33% for 2017.
|
CANF | Hot Stocks07:33 EDT Can-Fite BioPharma's Namodenoson enters Phase II trial for NAFLD/NASH - Can-Fite BioPharma provided an update on a Phase II clinical trial to evaluate its liver drug candidate Namodenoson in the treatment of non-alcoholic fatty liver disease, the precursor to non-alcoholic steatohepatitis. Can-Fite estimates the cost of this Phase II trial to be less than $1M. Pre-clinical data demonstrated that Namodenoson has hepato-protective effects; helps support liver function by reducing liver fat in NASH models as compared to placebo; inhibits and prevents the progression of liver fibrosis; improves liver function; and regenerates liver cells. Can-Fite will present its latest findings on Namodenoson's role in liver function at the 1st International Conference on Fatty Liver in Seville on June 1-3. Under the approved clinical protocol, the Phase II multicenter, randomized, double-blinded, placebo-controlled, dose-finding study of the efficacy and safety of Namodenoson in the treatment of NAFLD/NASH will enroll approximately 60 patients with NAFLD, with or without NASH.
|
BPMC | Hot Stocks07:30 EDT Blueprint Medicines sees cash and equivalents sufficient into 2H19
|
IDXX | Hot Stocks07:25 EDT IDEXX raises share repurchase authorization by additional 3M shares - IDEXX Laboratories announced that the repurchase by the company of up to an additional 3M shares of its common stock under its ongoing share repurchase program has been authorized. These shares are in addition to the 3,297,887 shares remaining under the company's share repurchase program as of April 28, pursuant to previous Board authorizations. The timing and amount of any repurchases will be at the discretion of the company's management.
|
PSTI | Hot Stocks07:20 EDT Pluristem: PLX-R18 cells did not increase leukocyte levels in non-irradiated NHP - Pluristem Therapeutics announced the promising results of its non-human primates, or NHP, pilot study for PLX-R18 as a treatment for Acute Radiation Syndrome, or ARS. The study, conducted and funded by the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health, or NIH, was designed to assess the safety and efficacy of PLX-R18 following intramuscular injection into irradiated and non-irradiated NHPs. Efficacy measures included survival as well as level of bone marrow function, which is affected by exposure to high levels of radiation as may occur in a nuclear accident or attack. While this pilot study was not powered to demonstrate statistical significance, all cohorts treated with PLX-R18 showed improved survival compared to cohorts that received placebo. The two lower dosages, 4 and 10 million cells per kilogram body weight, resulted in an 85% survival rate in irradiated NHPs compared to a 50% survival rate in the placebo treated control group. This pilot study also demonstrated a trend towards enhanced neutrophil and lymphocyte recovery. No serious adverse reactions were observed in non-irradiated NHPs, suggesting that in scenarios requiring the rapid treatment of large populations, such as in the case of a nuclear emergency, no determination of an individual's level of exposure would be required prior to treatment. These data will help inform a pivotal study designed to meet the requirements for a Biologics License Application submission under the FDA's Animal Rule regulatory pathway.
|
EE | Hot Stocks07:18 EDT El Paso Electric comments on Texas retail, New Mexico rate cases - On February 13, 2017, the Company filed with the City of El Paso, other municipalities incorporated in the Company's Texas service territory and the PUCT in Docket No. 46831, a request for an increase in non-fuel base revenues of approximately $42.5 million. The Company requested, pursuant to its statutory right, to have its new rates relate back for consumption on and after July 18, 2017, which is the 155th day after the filing of the rate case. The difference in rates that would have been billed will be surcharged or refunded to customers after the PUCT's final order in Docket No. 46831. The PUCT has the authority to require the Company to surcharge or refund such difference over a period not to exceed 18 months. The Company cannot predict the outcome or the timing of the rate case at this time. NMPRC Case No. 15-00109-UT required the Company to make a rate filing in New Mexico in the second quarter of 2017 using a historical test year ended December 31, 2016. On March 24, 2017, the Company, NMPRC Utility Division Staff and the New Mexico Attorney General filed a Joint Motion to Modify Filing Date Stated in Final Order requesting that the rate filing date be changed to no later than July 31, 2019, using the appropriate test year period. The joint request was approved by the NMPRC on April 12, 2017.
|
MDWD | Hot Stocks07:18 EDT MediWound announces 'successful' GMP audit by IMOH - MediWound announces the successful completion of a Good Manufacturing Practice, or GMP, audit of the company's facility in Yavne, Israel by the Israeli Ministry of Health, or IMOH. The audit was performed as part of the IMOH's routine evaluation of the Company's manufacturing facility for its proteolytic enzyme therapeutics. The audit concludes that MediWound's manufacturing facility conforms to the requirements of cGMP for the manufacture of sterile and biological medicinal products. This compliance status is valid for an additional three years from the time of the audit.
|
SAIC | Hot Stocks07:17 EDT SAIC awarded $27M task order - The Space and Naval Warfare Systems Center Pacific awarded Science Applications International Corp. a task order to provide the U.S. Marine Corps Forces Cyberspace Command and subordinate commands, including the Marine Corps Cyberspace Warfare Group and the Marine Corps Cyberspace Operations Group, with comprehensive cyber support services for systems architecture, cyber defense and offense, planning, information assurance, and engineering. The task order has a one-year base period of performance, two one-year options, and a total award value of approximately $27M if all options are exercised. Work will be performed in Fort Meade/Columbia, Maryland; Quantico, Virginia; Fort Bragg, North Carolina; Scott Air Force Base, Illinois; and Tampa, Florida.
|
MGEN | Hot Stocks07:16 EDT Miragen Therapeutics extends collaboration with Servier through September 2019 - Servier and Miragen Therapeutics announced that they have extended their research collaboration through September 2019. MicroRNA-92 has been added to the existing collaboration as a new therapeutic target, with the objective to start testing MRG-110 in humans within a year.
|
VSTM | Hot Stocks07:14 EDT Verastem to present follow-up data from DYNAMO study at ICML - Verastem announced that an abstract describing long term follow-up data from the DYNAMO study has been selected for oral presentation at the 14th International Conference on Malignant Lymphoma being held June 14 to June 17 in Lugano, Switzerland. DYNAMO is a Phase 2 clinical trial evaluating the safety and efficacy of duvelisib in patients with indolent non-Hodgkin lymphoma that are double refractory to both rituximab and chemotherapy. "The potential of duvelisib is supported by previously reported clinical data demonstrating anti-cancer activity and a manageable safety profile as an oral monotherapy in a wide range of lymphoid malignancies, including relapsed/refractory iNHL, chronic lymphocytic leukemia and T-cell lymphomas," said Hagop Youssoufian, MSc, MD, head of hematology and oncology development. "At Verastem, we are committed to investigating duvelisib's potential as it may represent a valuable treatment for patients with relapsed/refractory disease who currently have limited treatment options. We look forward to presenting these long term follow-up data from the DYNAMO study in iNHL at ICML this year." Duvelisib is an investigational, dual inhibitor of phosphoinositide 3-kinase-delta and PI3K-gamma, two enzymes that are known to help support the growth and survival of malignant B-cells and T-cells. PI3K signaling may lead to the proliferation of malignant B-cells and is thought to play a role in the formation and maintenance of the supportive tumor microenvironment. Duvelisib is currently being evaluated in late- and mid-stage clinical trials, including DUO, a randomized, Phase 3 monotherapy study in patients with relapsed or refractory CLL, and DYNAMO, a single-arm, Phase 2 monotherapy study in patients with refractory iNHL that achieved its primary endpoint of ORR upon top-line analysis of efficacy data. Duvelisib is also being evaluated for the treatment of hematologic malignancies through investigator-sponsored studies, including T-cell lymphoma.
|
APOP | Hot Stocks07:13 EDT Cellect says FDA provided pre-IND meeting minutes supporting ApoGraft IND - Cellect Biotechnology announced that the FDA provided Cellect with the pre-Investigational New Drug, or IND, meeting minutes supporting an IND submission in the U.S. for Cellect's flagship product, ApoGraft.
|
KLIC | Hot Stocks07:12 EDT Kulicke & Soffa reports Q2 gross margin 45.2%
|
UPS | Hot Stocks07:11 EDT UPS to acquire Nightline Logistics Group, terms not disclosed - UPS announced the company has entered into a definitive purchase agreement to acquire Nightline Logistics Group, an express delivery and logistics companies in Ireland. By integrating Nightline with UPS, customers will now have a wider array of both domestic and cross-border services. Nightline is a privately held company. Terms of the acquisition were not disclosed and the deal is subject to customary closing conditions, including regulatory approval.
|
GTXI | Hot Stocks07:10 EDT GTx announces results from preclinical studies of SARMS in DMD models - GTx announced the publication in the journal Human Molecular Genetics of results from preclinical studies supporting the potential efficacy of the company's SARMs, and in particular GTx-026, for Duchenne Muscular Dystrophy treatment. DMD is a rare genetic disorder characterized by progressive muscle degeneration and weakness, affecting approximately 18,000 boys in the United States. Studies examined the treatment of castrated wildtype mice, x-linked muscular dystrophy mice, and dystrophin and utrophin double mutant mice with GTx-026. In mdx mice, compared to vehicle-treated mice, GTx-026 treatment led to increased body weight, lean mass, grip strength, and improved cardiac and pulmonary function. In mdx-dm mice, compared to vehicle-treated mice, GTx-026 led to improved body weight, lean mass, and grip strength above baseline levels, leading to a 505 to 70% improvement in survival. Other SARMs in the company's portfolio, GTx-024 and GTx-027, showed similar positive effects on muscle mass, function, and histological characteristics. The peer-reviewed article, "Androgen Receptor Agonists Increase Lean Mass, Improve Cardiopulmonary Functions, and Extend Survival in Preclinical Models of Duchenne Muscular Dystrophy" appears in the journal Human Molecular Genetics.
|
GKOS | Hot Stocks07:06 EDT Glaukos completes enrollment for iDose Travoprost Intraocular Implant study - Glaukos announced the completion of patient enrollment in the U.S. Investigational New Drug Phase II study of its Travoprost Intraocular Implant with the iDose delivery system in patients with glaucoma. Implanted during a micro-invasive procedure, the iDose is designed to continuously elute therapeutic levels of medication from within the eye for extended periods of time. It is filled with a special formulation of travoprost, a prostaglandin analog used to reduce elevated intraocular pressure, and capped with a membrane designed for continuous controlled drug elution into the anterior chamber. When depleted, the implant can be removed and replaced in a similar, subsequent micro-invasive procedure. The 150-patient, multi-center, randomized, double-blind Phase II trial will evaluate two models of the iDose delivery system with different travoprost elution rates compared to a topical timolol maleate ophthalmic solution, 0.5%. The trial, which will assess preliminary safety and efficacy in lowering intraocular pressure in patients with open-angle glaucoma, will be unmasked after 12 weeks of follow-up, with a topline readout expected later in 2017. Results of the Phase II trial are expected to form the basis for the company's submission to the FDA to conduct expanded Phase III trials on the iDose delivery system.
|
TWX | Hot Stocks07:05 EDT Time Warner reports Q1 Turner revenues up 6% to $3.1B - Turner revenues increased 6% to $3.1B, due to increases of 12% in Subscription revenues and 16% in Content and other revenues, partially offset by a decline of 2% in Advertising revenues. HBO revenues increased 4% to $1.6B, due to an increase of 5% in Subscription revenues, partially offset by a decline of 1% in Content and other revenues. Warner Bros. revenues increased 8% to $3.4B, primarily due to higher television and theatrical revenues partially offset by lower videogames revenues.
|
OPB FMER | Hot Stocks07:03 EDT Opus Bank appoints Paul Grieg as lead independent director - Opus Bank (OPB) announced that its board of directors has created the new role of lead independent director and has appointed Director Paul Greig to this position, effective immediately. Greig joined Opus' board in April 2017 and previously served as chairman, president and CEO of FirstMerit (FMER) Corporation and its wholly-owned bank subsidiary, FirstMerit Bank.
|
TWX T | Hot Stocks07:03 EDT Time Warner CEO says on track to close AT&T merger before end of 2017 - Time Warner Chairman and CEO Jeff Bewkes said: "Looking ahead, we remain on track, pending completion of regulatory reviews and receipt of consents, to close our merger with AT&T Inc. before the end of 2017. We remain excited about the potential for this combination to accelerate the pace of innovation in our businesses."
|
TWX | Hot Stocks07:02 EDT Time Warner CEO says 'off to a strong start to 2017' - Time Warner Chairman and CEO Jeff Bewkes said: "We're off to a strong start to 2017, as we continue to benefit from the investments we're making in the best content while also developing new revenue streams that will drive growth and meet consumer demand for great experiences built around their favorite programming and brands. Warner Bros. delighted audiences in both film and television, with global hits in Kong: Skull Island and The LEGO Batman Movie and more series across broadcast for the current season than any other studio. Turner had another successful airing of the NCAA Division I Men's Basketball Tournament across platforms, while CNN grew its total day ratings by 21% among adults 25-54, and remained the leader in digital news. Together, Turner and Warner Bros. also launched our new Boomerang-branded SVOD service, adding to our growing portfolio of products that are reaching consumers directly."
|
DPW | Hot Stocks07:02 EDT Digital Power acquires Microphase in share exchange agreement - Digital Power announced the entry into an agreement that, upon consummation, will result in the acquisition of control of Microphase Corporation. MPC is a designer, developer, original equipment manufacturer of electronic components, devices and subsystems for the Defense, Aerospace and Telecommunication sectors. The transaction will be governed by a share exchange agreement executed as of April 28. The details of the transaction include the company acquiring 1,603,434 shares of MPC common Stock, representing 58% of MPC's issued and outstanding shares, or 50.2% on a fully diluted basis, from certain shareholders of MPC in exchange for an equivalent of 2,600,000 shares consisting of the company's Common Stock and Series D Convertible Preferred stock. The transaction is scheduled to close on May 25.
|
GRC | Hot Stocks07:00 EDT Gorman-Rupp announces transfer to NYSE - The Gorman-Rupp Company announced that it intends to transfer the listing of its common stock to the New York Stock Exchange from the NYSE MKT. The company's common stock, which will continue to trade under the ticker symbol GRC, is expected to commence trading on the NYSE effective May 16, 2017. The stock will continue to trade on the NYSE MKT until the transfer is complete. The transfer is expected to be seamless for the company's investors and shareholders.
|
LFUS | Hot Stocks06:53 EDT Littelfuse announces new 1M share repurchase plan - The company's previous share repurchase authorization expired on April 30, 2017 and has been replaced with a 1M share repurchase authorization effective through April 30, 2018. No shares were repurchased under the former authorization.
|
STRP T | Hot Stocks06:53 EDT Straight Path says 'mult-national telecom' makes $2.3B 'superior' proposal - Straight Path Communications (STRP) announced that the Straight Path board of directors determined that a revised offer from a "multi-national telecommunications company" to acquire 100% of the issued and outstanding shares of Straight Path for $135.96 per share, reflecting an enterprise value of approximately $2.3B, which will be paid in bidder stock in an all-stock transaction constitutes a "Superior Proposal" as defined in Straight Path's previously announced definitive agreement and plan of merger with AT&T (T) and Switchback Merger Sub Inc., dated as of April 9. The bidder previously submitted an unsolicited offer on April 24 to acquire 100% of the issued and outstanding shares of Straight Path for $104.64 per share, reflecting an enterprise value of $1.8B, which has been superseded by the revised offer announced today. Under the terms of the AT&T Merger Agreement, AT&T agreed to acquire Straight Path in an all-stock transaction in which Straight Path stockholders would receive $95.63 per share, reflecting an enterprise value of $1.6B, which would be paid using AT&T stock. Under the AT&T Merger Agreement, Straight Path is required to pay a $38M termination fee to AT&T if the Straight Path Board terminates the AT&T Merger Agreement in order to enter into an agreement with the Bidder. The bidder has agreed to pay the termination fee to AT&T on Straight Path's behalf in such event. Straight Path would be required to repay the bidder for the AT&T termination fee under certain circumstances in connection with a termination of the Bidder's merger agreement. At this time, Straight Path remains subject to the AT&T Merger Agreement and the Straight Path board has not changed its recommendation in support of the AT&T transaction, the existing AT&T merger agreement, or its recommendation that Straight Path's stockholders adopt the AT&T merger agreement.
|
QNST | Hot Stocks06:53 EDT QuinStreet enters strategic alliance with InsuraMatch - InsuraMatch announces it has entered into a series of agreements with QuinStreet whereby it will serve as QuinStreet's national agency sales and fulfillment center and acquire the QuinStreet Insurance Agency Sales Center, located in Altamonte Springs, Florida. While InsuraMatch will take over its Insurance Agency Sales Center operations, QuinStreet will continue to operate and invest in its real-time quoting platform and technologies, and on its industry-leading performance marketing business.
|
DLPH | Hot Stocks06:52 EDT Delphi announces plans for tax-free spin-off of Powertrain Systems segment - Delphi Automotive announced its intention to execute a tax-free spin-off of its Powertrain Systems segment into a new, independent publicly traded company. Immediately following the transaction, which is expected to be completed by March 2018, Delphi shareholders will own shares of both companies.
|
DLPH | Hot Stocks06:52 EDT Delphi announces plans for tax-free spin-off of Powertrain Systems segment
|
EL | Hot Stocks06:48 EDT Estee Lauder says 'cautious of decline in retail traffic' - Global prestige beauty remains a vibrant industry estimated to grow approximately 4% to 5%. There are risks related to social and political issues, terrorism, currency volatility and economic challenges affecting consumer behavior in certain countries. We are also cautious of the decline in retail traffic, primarily related to brick-and-mortar stores and certain tourist-driven doors in the United States. The Company's annual growth has consistently outpaced global prestige beauty and, despite these global issues, is expected to continue to grow at least one percentage point ahead of the industry for the fiscal year, which is our strategic goal. The Company expects sales growth to continue to progressively accelerate during its fiscal fourth quarter driven by strong innovation programs, greater outreach to target consumers for our fast-growing brands in winning channels, regular price increases, organic growth, easier comparisons in certain markets, improvement in Hong Kong, and accelerating incremental sales from recent acquisitions.
|
STRA | Hot Stocks06:35 EDT Strayer sees Q2 Strayer University enrollments up 6% y-o-y - Q2 total enrollments at Strayer University are anticipated to grow 6% to approximately 43,400 students from 41,029 students in the same period in 2016. New student enrollments are expected to increase approximately 8%, while continuing student enrollments are expected to increase approximately 5%. Anticipates Q2 revenue per student to decrease between 1% and 2%.
|
PTEN | Hot Stocks06:20 EDT Patterson-UTI reports April average 115 drilling rigs operating in U.S., Canada - Patterson-UTI reported that for the month of April 2017, the company had an average of 115 drilling rigs operating in the United States and two rigs in Canada. Average drilling rigs operating reported in the company's monthly announcements represent the average number of the company's drilling rigs that were operating under a drilling contract. The company cautioned that numerous factors in addition to average drilling rigs operating can impact the company's operating results and that a particular trend in the number of drilling rigs operating may or may not indicate a trend in or be indicative of the company's financial performance. The company intends to continue providing monthly updates on drilling rigs operating shortly after the end of each month.
|
SNGX | Hot Stocks06:18 EDT Soligenix receives FDA protocol clearance of SGX942 Phase 3 clinical trial - Soligenix announced that it has received FDA clearance to advance a pivotal Phase 3 clinical trial evaluating SGX942 for the treatment of oral mucositis in head and neck cancer, or HNC, patients being treated with chemoradiation, or CRT. Soligenix plans to begin this study in the second quarter of 2017.
|
ESES | Hot Stocks06:17 EDT Eco-Stim Energy awarded new long term contract, value should exceed $50M - Eco-Stim Energy announced that the company has been awarded a two-year contract with the largest operator in Argentina for their tight gas completions program. The effective date for this contract was April 1 and substantial work has already been executed under this contract. This contract will provide a guaranteed minimum level of compensation to EcoStim although the operator expects the completion program to generate over $50M in completions work over the contract's term. As tight gas drilling expands over the next several years in Argentina with the benefit of government supported natural gas prices, this relationship should provide the Company with a unique opportunity to participate in further growth opportunities.
|
ERIC | Hot Stocks06:09 EDT Moody's downgrades Ericsson to Ba1; outlook stable - Moody's Investors Service has downgraded to Ba1 from Baa3 the senior unsecured long-term rating and to (P)Ba1 from (P)Baa3 the senior unsecured medium term note program rating of Telefonaktiebolaget LM Ericsson, a global provider of telecommunications equipment and related services to mobile and fixed network operators. Concurrently, Moody's has assigned Ericsson a Ba1 corporate family rating and a Ba1-PD probability of default rating, in line with the rating agency's practice for corporates with non-investment-grade ratings. The outlook on all ratings is stable. "The downgrade of Ericsson's ratings reflects the anticipated negative impact on the company's operating earnings and cash flow in 2017 and 2018 due to rising restructuring charges and provisions, as recently announced by the company, leading to credit metrics that will no longer be commensurate with investment-grade ratings," says Alejandro Nunez, a Moody's Vice President -- Senior Analyst and lead analyst for Ericsson.
|
WG | Hot Stocks06:09 EDT Willbros Group executes new contracts valued at $70M - Approximately $28M of these new awards were consummated in late Q1 2017 and are included in March 31, 2017 backlog as follows: The Tank services business executed a new tank construction contract valued at $21M; and Oil & Gas segment was awarded facility work approximating $7M. Work on both of these projects commenced in March. New awards received in April 2017 totals approximately $42M.
|
SUM | Hot Stocks06:04 EDT Summit Materials raises FY17 CapEx view to $140M-$160M - Including the impact of six acquisitions completed on a year-to-date basis, the Company is raising its gross capital expenditure guidance by $5M to a range of $140M-$160M for the full-year 2017. Revised capital expenditure guidance includes several maintenance and profit-improvement projects. Longer-term, the Company expects gross capital expenditures to approximate 7%-8% of net revenue per annum.
|
SUM | Hot Stocks06:03 EDT Summit Materials raises FY17 adjusted EBTIDA to $430M-$445M from $420M-$425M - "Given contributions from recently completed acquisitions, together with expectations for continued organic growth within our business, we have increased our full-year Adjusted EBITDA guidance," continued CEO Hill. "For the full-year 2017, we project total Adjusted EBITDA in the range of $430 million to $445 million, up from the prior range of $410 million to $425 million. On a year-to-date basis, we have invested $180 million across six transactions, positioning us to meet or possibly exceed our full-year acquired EBITDA target of $40 million to $60 million per year. We are pleased with our strong start to the year and look forward to building on this momentum as we continue to create value for our shareholders."
|
NTEC | Hot Stocks05:52 EDT Intec Pharma CEO Zeev Weiss resigns, Giora Carni appointed interim CEO - Intec Pharma announces that Zeev Weiss, CEO and a director of the company, is resigning from both positions effective immediately to pursue other professional opportunities. Weiss will serve as a clinical and business development consultant to Intec Pharma. The board has appointed Giora Carni, a director since 2006 and CEO of Intec Pharma from 2006 to 2014, as Interim CEO while a search for a new CEO has been initiated.
|
PLNT | Hot Stocks05:51 EDT Planet Fitness raises FY17 adjusted EPS view to 74c-77c - Raises FY17 revenue view to $405M-$415M. Raises FY17 system-wide same store sales growth to 7%-8% range.
|
APC | Hot Stocks05:51 EDT Anadarko issues statement regarding Firestone accident - Anadarko Petroleum provided the following statement regarding the Frederick-Firestone Fire Protection District's results of investigation into the tragic accident in Firestone, Colo., which occurred on April 17. "I know I speak for everyone at Anadarko when I say that our thoughts and prayers remain with the Martinez and Irwin families as they continue to mourn the loss of their loved ones," said Al Walker, Anadarko Chairman, President and CEO. "The safety of our employees and the people who live and work in the communities in which we operate is our number one priority. Consistent with that, and out of an abundance of caution, last week we shut in our vertical wells in the Oak Meadows area and throughout the basin. We hope that doing so also provided some additional reassurance to the community in the wake of this tragic accident. We will continue to take all necessary and appropriate steps in that regard, and will continue to cooperate fully with all ongoing investigations to ensure we fully understand the basis for the fire district's conclusions and that no stone is left unturned prior to any final determinations." The company also will continue to work with the Colorado Oil and Gas Conservation Commission on additional steps or actions the agency deems necessary.
|
OLN | Hot Stocks05:51 EDT Olin Corp. sees FY17 CapEx $300M-$350M - Excluding the investment associated with acquiring additional cost-based ethylene.
|
FUN | Hot Stocks05:49 EDT Cedar Fair expects 'another record year' in FY17
|
PIRS AZN | Hot Stocks05:37 EDT Pieris Pharmaceuticals, AstraZeneca entter collaboration - Pieris (PIRS) announced a strategic collaboration in respiratory diseases with AstraZeneca (AZN) to develop novel inhaled drugs that leverage Pieris' Anticalin platform, including its lead preclinical drug candidate, PRS-060. Anticalin molecules are engineered proteins which can mimic antibodies by binding to sites either on other proteins or on small molecules. They are smaller than monoclonal antibodies, offering the potential of direct delivery to the lung. Under the collaboration, Pieris will be responsible for advancing its preclinical lead candidate, PRS-060, into Phase 1 clinical trials in 2017. PRS-060 is an Anticalin against interleukin-4 receptor alpha with potential in asthma. AstraZeneca will fund all clinical development and subsequent commercialization programs and Pieris has the option of co-development and co-commercialization in the US from Phase 2a onwards. In addition, the parties will collaborate to progress four additional novel Anticalins against undisclosed targets for respiratory diseases with Pieris having the option to co-develop and co-commercialize in the US two of these programs.
|
PIRS AZN | Hot Stocks05:36 EDT Pieris Pharmaceuticals, AstraZeneca entter collaboration - Pieris announced a strategic collaboration in respiratory diseases with AstraZeneca to develop novel inhaled drugs that leverage Pieris' Anticalin platform, including its lead preclinical drug candidate, PRS-060. Anticalin molecules are engineered proteins which can mimic antibodies by binding to sites either on other proteins or on small molecules. They are smaller than monoclonal antibodies, offering the potential of direct delivery to the lung. Under the collaboration, Pieris will be responsible for advancing its preclinical lead candidate, PRS-060, into Phase 1 clinical trials in 2017. PRS-060 is an Anticalin against interleukin-4 receptor alpha with potential in asthma. AstraZeneca will fund all clinical development and subsequent commercialization programs and Pieris has the option of co-development and co-commercialization in the US from Phase 2a onwards. In addition, the parties will collaborate to progress four additional novel Anticalins against undisclosed targets for respiratory diseases with Pieris having the option to co-develop and co-commercialize in the US two of these programs.
|
HLF | Hot Stocks05:34 EDT Herbalife issues voluntary recall for Protein Bar - Peanut Butter - Herbalife is voluntarily recalling certain lots of its Protein Bar - Peanut Butter because the product may contain a trace amount of fish gelatin, which was added to the product as part of a flavoring ingredient provided by a third-party supplier. The amount of gelatin in the finished product is extremely low. The gelatin is a highly processed collagen from fish skin, which contains a negligible amount of parvalbumin, a fish allergen. There have been no reports to date of any illnesses or adverse health effects associated with the affected product. Nonetheless, the company is taking this voluntary action out of an abundance of caution. The FDA has been notified of this recall. The product was distributed in the U.S. from 6/30/2016 to 4/7/2017, exclusively to individual independent distributors as 14-pack cartons. Lots numbers affected are 066539A11, 066553A11, 066601A11, 066660A11, 066688A11, and 066691A11.
|
PRGO | Hot Stocks05:32 EDT Perrigo discloses federal investigation into drug pricing - Perrigo announced that search warrants were executed at the company's corporate offices associated with an ongoing investigation by the U.S. Department of Justice Antitrust Division related to drug pricing in the pharmaceutical industry. As has been previously disclosed by a number of companies, the Antitrust Division has been looking at industry-wide pricing practices. The company is taking this investigation seriously and is cooperating with the appropriate authorities.
|